Abstract
Gastrointestinal motility disorders pose a major clinical challenge because of the limitations of diagnostic tests and the lack of efficacious therapeutic options. Gastrointestinal motility disorders comprise heterogeneous conditions that may affect any area of the digestive tract resulting from abnormality of enteric neuromuscular function. Motility disorders are frequently chronic and may markedly affect patients’ quality of life. Despite significant progress has been made over the last years, the exact nature and pathophysiological mechanisms of most gastrointestinal motility disorders remain largely unknown. Unfortunately, most dysmotility disorders cannot be cured and treatment are only offered to relieve symptoms, reduce morbidity and mortality, and improve quality of life. Surgery has a pivotal role in managing patients with motility disorders representing the treatment of choice in different conditions or an important intervention to be associated with medical therapies.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Achalasia
- Heller
- POEM
- GERD
- Fundoplication
- Paediatric intestinal pseudo-obstruction
- Enterostomies
- Gastrostomy
- Jejunostomy
- Ileostomy
- Colostomy
- Hirschsprung’s disease
- Constipation
- Faecal incontinence
- HAEC
Introduction
Gastrointestinal motility disorders pose a major clinical challenge because of the limitations of diagnostic tests and the lack of efficacious therapeutic options. Gastrointestinal motility disorders comprise heterogeneous conditions that may affect any area of the digestive tract resulting from abnormality of enteric neuromuscular function. Motility disorders are frequently chronic and may markedly affect patients’ quality of life. Despite significant progress has been made over the last years, the exact nature and pathophysiological mechanisms of most gastrointestinal motility disorders remain largely unknown. Unfortunately, most dysmotility disorders cannot be cured and treatment are only offered to relieve symptoms, reduce morbidity and mortality, and improve quality of life. Surgery has a pivotal role in managing patients with motility disorders representing the treatment of choice in different conditions or an important intervention to be associated with medical therapies.
This chapter discusses surgical approaches to the main motility disorders focusing on indications, techniques, and postoperative outcomes. Principal areas of controversy and risks/benefits considerations concerning surgery for motility disorders are debated.
Since the needs of patients with complex medical conditions, as children with gastrointestinal motility disorders are, exceed the boundaries of competence of a single specialist, the incorporation of medical and surgical skills is strategic, as suggested by Peter Cotton [1] who firstly described the advantages of the integrated activity of the “digestivists.”
Achalasia
Achalasia is a life-long rare debilitating condition characterized by an incomplete lower esophageal sphincter (LES) relaxation and absence of esophageal peristalsis, which leads to slow or absent bolus transit into the stomach (Chap. 22). Diagnosis of achalasia in children is generally made between 7 and 15 years of age, with a mean age of 10.9 years and predominance for male sex. Because of the improved knowledge about achalasia, incidence is constantly increasing and ranges between 0.1 and 0.18/100,000 children per year [2, 3].
Clinical presentation of achalasia in adults and adolescents includes dysphagia (94%), regurgitation (76%), heartburn (52%), chest pain (41%), and weight loss (35%) [2]. Younger children and infants may also present atypically with recurrent pneumonia, nocturnal cough, aspiration, hoarseness, feeding difficulties, and failure to thrive. Achalasia in children is often misdiagnosed as gastroesophageal reflux disease (GERD) or may present in a similar fashion with other conditions, such as eating disorders, eosinophilic esophagitis, or asthma, which often result in a significant diagnostic delay [3, 4].
Clinical history, upper endoscopy, and esophagogram are useful to suspect achalasia and to exclude other conditions such as structural (e.g., peptic stricture, congenital stenosis), and mucosal esophageal disease (e.g., eosinophilic esophagitis). The clinical reference for the diagnosis of achalasia is the high-resolution manometry (HRM) which allows to easily identify impaired relaxation of the lower esophageal sphincter and aberrant peristalsis. Achalasia is categorized by using Chicago Classification 4.0 (CC) into three subtypes according to HRM patterns of esophageal body contractility: type I, minimal/absent contractility in the esophageal body; type II, intermittent periods of panesophageal pressurization; type III (spastic) with premature or spastic esophageal contractions. By using metrics from HRM CCv 4.0 defines other esophageal motility disorders that may benefit from surgical treatment such as esophagogastric junction (EGJ) outflow obstruction (EGJOO), diffuse esophageal spasm (DES), and nutcracker/jackhammer esophagus (JH) [5].
Classifying achalasia subtypes by the Chicago Classification may offer valuable data on prognosis and can be used to direct treatment choice [6].
As no curative treatment is currently available, once the diagnosis is established, the therapeutic aim is the disruption of non-relaxing circular muscle of esophagus and esophagogastric junction (EGJ), in order to facilitate the passage of the bolus into the stomach and to prevent further esophageal dilatation, resulting in an improvement of symptoms [7].
Traditional management of pediatric achalasia includes step-wised esophageal dilation and surgery [6, 8].
The surgical approach in pediatric esophageal achalasia has progressed from an open surgery to a minimally invasive surgery, comprising laparoscopic or robotic Heller’s myotomy (LHM) with or without Dor’s anti-reflux fundoplication, and peroral endoscopic myotomy (POEM) techniques [9].
In selected patients who are not eligible for definitive surgical management, alternative less effective long-term options include Botulinum toxin injection, calcium channel blockers, and long-acting nitrates, treatments used mainly in adult population, with variable results [10].
Laparoscopic or Robotic Heller’s Myotomy with or without Fundoplication
Since satisfactory outcomes occurred in almost 95% of patients, minimally invasive treatments for achalasia are equally effective to open techniques. Laparoscopy is now the preferred approach for Heller’s myotomy [9, 11].
The patient is supine in reverse Trendelenburg position. Endotracheal intubation is required for the procedure. A big orogastric tube is generally inserted.
The key elements of Heller’s technique are as follows:
-
(A)
incision of the umbilicus
-
(B)
introduction of the 30° laparoscope through the Hassan trocar and, therefore, of the remaining trocars under direct visualization
-
(C)
exposure of the gastroesophageal junction
-
(D)
section of the phrenoesophageal ligament to expone the anterior esophagus and cardias
-
(E)
myotomy
-
(F)
Dor’s fundoplication (optional)
-
(G)
entry points closure
One of the most debated aspects surrounding Heller’s myotomy concerns the opportunity to perform an anti-reflux procedure after the esophageal myotomy to compensate the mobilization of cardias. A prospective randomized trial by Richards et al. showed that the addition of an anterior partial fundoplication significantly decreased the incidence of postoperative gastroesophageal reflux, when compared with no fundoplication. Thus, according with main evidence, routine application of Dor fundoplication is the standard approach. The addition of a Dor fundoplication seems not to affect the postoperative functional outcome of an esophageal myotomy [11, 12]. Similar results are reported with the Toupet technique [13]. We must consider that an impaired esophageal emptying is frequently reported, especially in type I achalasia. The workup or recurrence is often more complicated when a flap valve is associated.
Furthermore, despite laparoscopic myotomy is an overall safe technique with excellent outcomes, complications can occur even in expert hands: rates of esophageal mucosal layer perforation up to 15% have been reported, especially after preoperative treatments (e.g., pneumatic balloon dilatation) [14,15,16].
The latest technological advances suggest how robotic Heller myotomy, combined with a fundoplication, incorporates all of the advantages of laparoscopic surgery with the added benefits of improved 3-dimensional visualization, increased degree of instrument freedom, human tremor control, and restoration of proper hand-eye coordination. These aspects combine to determine a decreased rate of complications, especially regarding the risk of intraoperative perforation (reduced from 15% to 0%), while maintaining the same effectiveness of traditional laparoscopic myotomy [15,16,17,18]. Disadvantages of the robotic approach are the high costs and increased operative times due to the setting of the robot, which can be partially reduced by improving the training of the operative team [16, 17].
PerOral Endoscopic Myotomy (POEM): A New Incisionless Approach to Esophageal Achalasia
POEM Technique
POEM is a well-established treatment for achalasia first described by Pasricha et al. in 2007 in a porcine model, performed by H. Inoue et al. in 2010 in humans [19, 20] and recently introduced into pediatric surgical and gastroenterological practices [10, 21,22,23].
This technique represents an incisionless approach both to the esophagus and the LES made possible by the ingenious concept of creating a submucosal tunnel preventing mucosal thermal damage during the myotomy. Once submucosal tunnel has reached the gastric side, a myotomy is performed for the total length of the tunnel itself. The mucosal incision is closed by using standard clips.
Thus, the elements of POEM technique are as follows (Fig. 50.1):
-
(A)
mucosal incision
-
(B)
submucosal tunnel creation
-
(C)
myotomy
-
(D)
entry point closure
The entry point site varies depending on the manometry findings but is typically 10–15 cm proximal to the EGJ.
The tunnel can be created in the anterior (2 o’ clock) or posterior (5 o’ clock) wall of the esophagus according to the operator’s preference and previous treatments in patient’s history. This possibility to choose between two alternative tunnel’s orientations is particularly profitable in the management of recurrent symptoms after POEM or LHM as it allows to avoid the fibrosis caused by previous myotomy [24].
Risk of GERD and Comparison with LHM
Because no anti-reflux flap valve is generally created, gastro-esophageal reflux disease (GERD) after POEM is postulated to be higher than LHM. In a comparative trial, POEM was associated with an increased risk of post-intervention GERD when compared with LHM, with high concordance rates across the three main parameters assessed: reflux- symptoms, abnormal pH-monitoring and endoscopic diagnosis of esophagitis [8]. A recent systematic review estimated a cumulative after-POEM gastroesophageal reflux rate of 17.8% (CI 95%, 14.2–22.0%) [25] compared to a risk between 4% and 16.8% of postoperative GERD in patients undergoing LHM in different studies [8, 26,27,28]. However, the risk of severe, unresponsive esophagitis is quite low [5]. There are conflicting opinions on the value of adding fundoplication at the time of myotomy. Some authors, in fact, have questioned the real utility to perform an anti-reflux procedure immediately after myotomy, because of the residual impairment of esophageal peristalsis [29]. Furthermore, an outlet obstruction can impair the post-surgical evaluation of a recurrent dysphagia.
Therefore, the management of recurrent dysphagia is easier after POEM comparing to LHM because no flap valve is performed. For this reason, supported by many studies reporting complete GER resolution with medical management[30], many pediatric surgeons perform Heller procedure without flap valve as first choice in children with achalasia and a second anti-reflux procedure only in selected patients with GERD unresponsive to proton pump inhibitor, after the pubertal spurt.
Nevertheless, a diligent follow up with pH-impedance monitoring and endoscopic surveillance of patient underwent POEM is required, to prevent the long-term theoretical risk of chronic esophageal inflammation.
Regardless of the risk of postoperative GERD, because of the different development eras for the two techniques, it remains difficult to compare the effectiveness of POEM and LHM. Both procedures appear to be safe and effective in symptoms relief. The hospitalization is also comparable [31]. The main advantage of POEM over LHM lies in its ability to access the thoracic esophagus, to adapt the length of the myotomy to the manometric findings and to avoid distal inflamed mucosa. POEM is particularly indicated in patients with type III achalasia who benefit from an extended tailored myotomy that involve the entire length of the spastic segment noted on esophageal HRM, which is unfeasible with LHM [6, 32].
Effectiveness and Safety Profile
Clinical success after POEM is most evaluated using the Eckardt score [33]: a score of ≤3 is judged to be a clinical success. However, this score only evaluates any weight loss, but does not consider the growth trend and its post-operative recovery, a critical aspect in the evaluation of post-surgical outcome in children.
Other more objective post-procedure efficacy indicators are esophageal HRM and timed barium esophagogram [34].
Mid-term effectiveness results in adults are extremely satisfactory: Eckardt score is less than three points in 98% of patients and post-operative stay is generally around 3–4 days.
Regarding the manometric parameters, a meta-analysis by Akintoye et al. showed that the average LES and IRP measured before the procedure, 33 ± 1.7 and 30 ± 1.4 mmHg, respectively, decreased to 14 ± 1.2 and 13 ± 1.6 mmHg, respectively, 6 months after the POEM. The timed barium esophagogram also recorded equally satisfactory results: prior the procedure the average heights of the barium column were 14 ± 2.3 and 9.7 ± 1.9 cm at 1 and 5 min, respectively; the column heights decreased to 4.2 ± 0.77 and 2.6 ± 0.72 cm at 1 and 5 min, respectively, after the POEM [34] (Fig. 50.2).
Data in pediatric population are quite limited, despite the increasing spread of this technique even in children in the last decade. Recently, a systematic review by Zhong et al. analyzed 11 of the most authoritative studies of last years for a total sample of 385 children undergoing POEM, demonstrating cumulative technical and clinical success rates of 97.4% (CI 95%, 94.7–98.7%) and 92.4% (CI 95%, 89.0–94.8%), respectively. After POEM, the Eckardt score was significantly decreased by 6.76 points (CI 95%, 6.18–7.34, p < 0.00001) and the lower esophageal sphincter pressure was significantly reduced by 19.38 mmHg (95% CI, 17.54–21.22, p < 0.00001).
Safety profile in expert hands is extremely satisfactory, with a pooled major adverse events rate of 12.8% (CI 95%, 4.5–31.5%) in the meta-analysis of Zhong et al. [25]. Overall, the most common complication is represented by mucosal perforation that is reported in up to 3% of POEMs, and it is generally demonstrated by day after endoscopy or esophagogram. Management of mucosal perforation after POEM is generally conservative (prolonged fasting, antibiotics, and endoscopic treatment). Capnoperitoneum/capnomediastinum requiring decompression, pleural effusion, and submucosal bleeding are also reported as major adverse events. No mortality or emergency surgery after POEM has been reported [35].
Conclusions
In conclusion, a high index of suspicion and prompt investigations are required to detect achalasia in children. Esophageal HRM has a key role in diagnosing achalasia and, by categorizing the disorder in subtypes, it offers important information on prognosis and in driving the choice of treatment.
POEM is a safe and effective emerging technique in the pediatric endoscopy settings with high levels of expertise, according to the most recent literature and to the experience with the adult population. With rates of efficacy, safety and long-term effects largely comparable to those of LHM, POEM could quickly become the first-line therapy of pediatric achalasia when an expert operator is available.
Gastroesophageal Reflux Disease
Although antireflux surgery for gastroesophageal reflux disease (GERD) is one of the most performed procedures in pediatric surgery [36], indications are poorly defined. Therefore, there is a large degree of heterogeneity among centers regarding approaches of surgery for GERD [37]. It should be pointed out that, despite fundoplication has an unquestioned value in preventing reflux-related complications and improving quality of life in many selected children, it is far from an uncomplicated procedure especially when offered to the “wrong” patient. Indeed, the procedure permanently alters gastroesophageal anatomy and function, and may promote a variety of complications [38].
Current guidelines on pediatric gastroesophageal reflux disease (GERD) of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) stated that “only patients with clearly proven GERD should be considered for surgery” but they also highlight that obtaining un objective and definitive proof of GERD in children is still an unresolved issue. Indeed, guidelines pointed out also that “to date no gold standard diagnostic tool exists for the diagnosis of GERD in infants and children” [39].
Indications for Antireflux Surgery
In clinical practice, children candidate for surgery usually exhibit persistent symptoms despite optimized medical therapy with proton pump inhibitors (PPIs) are suffering from GERD-related complications (e.g., reflux-related pulmonary aspiration or peptic esophagitis) or have predisposing anatomic anomalies (e.g., a large hiatal hernia). Selection of patients for antireflux surgery in pediatrics is traditionally based on a combination of symptoms attributed to reflux, the presence of underlying pathologies that may predispose the development of severe GERD (e.g., neurologic impairment, esophageal atresia), and a preoperative workup that mainly includes upper gastrointestinal endoscopy, esophageal pH monitoring (or pH impedance) and upper gastrointestinal contrast studies [40]. Nonetheless definitive indication for antireflux surgery predominantly relies on individual experience and attitude that greatly varies among centers. Most of the pediatric literature consists of retrospective series in which details concerning diagnosis of GERD and previous medical therapy are lacking [39].
Therefore, recommendations on antireflux surgery in infant and children are only based on expert opinion and suggest that surgery can be considered when GERD is associated with:
-
1.
life-threatening complications (e.g., cardiorespiratory failure) of GERD after failure of optimal medical treatment.
-
2.
symptoms refractory to optimal therapy, after appropriate evaluation to exclude other underlying diseases.
-
3.
chronic conditions (i.e., neurologically impaired) with a significant risk of GERD-related complications.
-
4.
the need for chronic pharmacotherapy for control of signs and/or symptoms of GERD [39].
Over the last years, the number of surgical fundoplication in adults has steadily declined owing to concerns about complications, limited durability, and the need for reoperation in some patients [41]. In line, data collected from a national administrative dataset including 52 children’s hospitals across the United States documented a threefold decrease in volume for fundoplication in children with GERD over the last decade [42].
Fundoplication
Different surgical options have been described to treat GERD, but the most common operation is the fundoplication. During fundoplication the gastric fundus is wrapped around the lower part of the esophagus to create a mechanical valve at the level of the esophagogastric junction. This operation decreases the amount of reflux by increasing the baseline tone of the lower esophageal sphincter (LES), decreasing the nadir pressure during swallow induced LES relaxation and the number of transient LES relaxations (TLESRs), and, by lengthening the intra-abdominal portion of the esophagus, accentuates the angle of His, and, when present, reduces a hiatal hernia [38].
Different fundoplication approaches exist, but they can be broadly differentiated in total fundoplication (Nissen procedure), which wraps the fundus 360 degrees around the esophagus, and partial fundoplication, with less than 360-degree wrap (the most common are 270° posterior fundoplication [Toupet procedure] and a 180° anterior fundoplication [Dor and Thal procedure]).
All types of fundoplication can be carried out as either open or laparoscopic surgery [43]. Follow-up studies suggested that laparoscopic fundoplication was associated with improved outcomes (hospital stay, costs, infection and surgical complications, and unplanned readmissions) compared with the open procedure [44, 45]. Therefore, laparoscopic fundoplication is currently regarded as the operation of choice by most pediatric surgeons [46, 47] and considered the gold standard for surgical treatment of severe GERD [47]. However, findings from randomized studies failed to show that laparoscopic fundoplication is superior to open approach with regard to short-term clinical outcomes while, in the long-term children operated with laparoscopy have a higher recurrence rate of GERD. Despite laparoscopic approach leads to a reduced incidence of retching, it shows a higher recurrence rate of GERD than open surgery [48,49,50]. A meta-analysis comparing open and laparoscopic fundoplication in six studies (four retrospective and two prospective studies) for a total of 721 patients showed no significant differences in GERD recurrence at 12 months, while other outcomes (operative time, hospital stay, start of feeding, and 30-day morbidity) generally favored laparoscopic approach. The significant heterogeneity among studied and the overall poor methodological quality considerably limit the interpretation of these results [51].
Data comparing the fundoplication technique and in particular outcomes of partial versus complete fundoplication in children are even more scarce. A single randomized controlled trial compared outcomes between partial (Thal) versus complete fundoplication in children found that in the long-term Nissen fundoplication had a significantly lower recurrence rate of symptoms than a Thal fundoplication in patients with neurological disorders while no significant difference between them was observed in non-neurologically impaired children. However, patients undergoing partial fundoplication have a statistically significant lower risk of postoperative dysphagia requiring endoscopic dilation compared to children undergoing complete fundoplication [52].
Other Anti-Reflux Operations
Esophagogastric Disconnection or Dissociation
Total esophagogastric disconnection is a radical procedure that has been developed to treat children with neurological impairment (NI) with intractable GERD unresponsive to other approaches. It involves the disconnection of the esophagus from the stomach and anastomosis with the jejunum. The patient is then fed through a permanent gastrostomy without risk of reflux [53].
This procedure has been advocated for NI children with severe neurological compromise with inability or contraindication (unsafe swallowing) to be orally fed [54, 55].
Prolonged postoperative care and occurrence of possible complications including malabsorption, need for prolonged enteral feeding, dumping syndrome, and Barrett’s esophagus have been reported after total esophagogastric disconnection [56,57,58,59,60].
ESPGHAN guidelines recommend restricting the indication for total esophagogastric disconnection, as an alternative of classical antireflux surgery, to selected cases in children with NI [61].
Jejunal Feeding
Post-pyloric feeding has been proposed as an alternative to antireflux surgery in patients with severe GERD. Indeed, it represent a less invasive and reversible procedure compared with fundoplication. Gastro-jejunostomy (PEG-J) is preferred procedure to gain jejunal access, alternatives are naso-jejunal tube placement or surgical transcutaneous jejunostomy. To minimize the risk of dislodgement in the stomach, the tube needs to be ideally passed beyond the ligament of Treitz. When PEG-J is in place, the gastric port can be used to give medications, vent air, and drain fluids while jejunal nutrition can be simultaneously given through the jejunal port. Main drawbacks are the need of continuous feeding regimes and the risk of frequent jejunal tube dislodgement requiring replacement, while major surgical complications have recently been identified in 6% of patients [62]. A metanalysis comparing outcomes for fundoplication and PEG-J in children with NI failed to show significant superiority of one over the other approach [63]. In another study, neither treatment option is clearly superior in preventing the subsequent aspiration pneumonia or improving overall survival for NI children [64].
Considering the risks and benefits associated with the therapeutic options, it is advisable that the choice of one over the other should involve a decision-making process fully shared with families.
Surgical Techniques
As stated, laparoscopic technique via transabdominal is preferred over open surgery for most patients undergoing fundoplication.
The basic laparoscopic equipment includes insufflation with CO2, monitors, laparoscopic instruments (30-degree angled laparoscope, four trocars ranging from 3–5 to 10 mm, liver retractor, laparoscopic needle holder, laparoscopic grasper, electrosurgery hook, scissors), suction/irrigation system, electrocautery, and/or laparoscopic ultrasonic energy device dissector.
To perform laparoscopic fundoplication, the patient is placed supine in the reverse Trendelenburg position, with the legs abducted on straight leg boards, with the surgeon between the patient’s legs, the assistant surgeon on the patient’s right, and the camera holder to the left.
The initial port (5 or 10 mm) is placed at the level of the umbilicus, using a closed or open technique, and three additional ports are placed under direct vision of the laparoscope.
The laparoscopic procedure ensures a meticulous dissection and full mobilization of the lower esophagus (Fig. 50.3). These preconditions are of great importance in performing safely a floppy wrap.
Thal Fundoplication
Thal fundoplication is a simple intervention which fixes the distal esophagus within the abdomen and produces an acute angle of His. It is a 90-degree anterior wrap.
The procedure involves three steps:
-
1.
Dissection of the abdominal esophagus and crura, then ligation of the esophageal hiatus on the dorsal side of the esophagus with non-absorbent sutures.
-
2.
Reconstruction of His angle through two more sutures between the left wall of the abdominal esophagus and the fundus of the stomach. Anchoring suture is added to the left crus of the diaphragm.
-
3.
Anterior wrapping: The greater curvature of the stomach dome is sutured to both the right wall of the abdominal esophagus and the right crus of the diaphragm to prevent wrap migration. The stomach and the right wall of the esophagus are sutured with two more sutures and wrapping it over 180° anterior [65].
Dor Fundoplication
Dor fundoplication is an anterior 180-degree wrap originally described by the surgeon Dor in 1962.
The technique implicates the dissection of the hiatus using a vessel sealer or an electro-cautery shears or hook. The gastro-hepatic ligament is opened to find the right crus, then the dissection is continued across the apex of the hiatus to expose the left crus to the base of the angle of His. The esophagus is dissected until the anterior mediastinum in order to ensure adequate intra-abdominal esophageal length. Any herniation is repaired with two to three interrupted not absorbable stitches between the right and left crura. Approximation of the crura is usually performed posterior to the esophagus, although anterior closure may be appropriate.
An anterior 180-degree Dor fundoplication is created by suturing the anterior wall of the gastric fundus to the left and right crura and the diaphragmatic hiatus (Fig. 50.4). Stitches are placed through the right side of the fundus and through the adjacent left crus to recreate the angle of His. An apex suture is placed through the top of the fundus and the apex of the diaphragmatic hiatus. The posterior left fundus is then sutured to the right crus to complete the 180-degree fundoplication [66].
Toupet Fundoplication
Toupet fundoplication is first devised in 1963 by Andre Toupet.
It is a 270-degree posterior wrapping of the stomach around the esophagus, that leave the anterior esophageal hemicircumference free to avoid the inability to belch.
The procedure includes the division of the gastro-hepatic ligament using the ultrasonic shears oh hook, the diaphragmatic crura dissection and the mobilization of the abdominal esophagus. A retroesophageal window is created bluntly from the right side with care not to injure the posterior vagus nerve. After that, the posterior wall of the fundus is pulled behind the esophagus to the right side and it is fixed to the esophagus and to the right crus with three to five not absorbable sutures. The same procedure is performed on the left side, where the fundus is fixed to the esophagus and the left crus (Fig. 50.5). The vagus nerve should be identified and preserved at all steps of the operation. The hiatus should be closed by one or two stitches when it is very enlarged (Fig. 50.6) [67].
Nissen Fundoplication
Nissen fundoplication, a total (360°) wrap fundoplication, is the most common antireflux operation, performed by Rudolph Nissen [68].
The first steps of the procedure are the same as the Toupet fundoplication and consist mainly of left and right crural dissection, mobilization of the intra-abdominal esophagus, and division of the short gastric vessels. Preservation of vagus nerves is recommended to ensure a better functional outcome. In cases of hiatal hernia, in which the fundus may slide up through the enlarged esophageal hiatus of the diaphragm, the right and left crura should be reapproximated posteriorly, utilizing two or three permanent sutures. To conclude, the posterior fundus is passed behind the esophagus from left to right and it is closed anteriorly using two or three non absorbable sutures (Figs. 50.7, 50.8, and 50.9). The most superior suture can incorporate a small piece of anterior esophagus and right crus to help secure the wrap. An oro-gastric tube can also be used to calibrate the wrap and prevents excessive narrowing of the esophagus.
Esophago-Gastric Dissociation
The esophago-gastric dissociation is an alternative antireflux surgery for neurologically impaired children, described in 1997 by Adrian Bianchi.
The original technique (Fig. 50.10) involved a fully mobilization of the distal esophagus that was transected above the gastroesophageal junction; the gastric end was over sewn. An isoperistaltic Roux-en-Y loop of jejunum on a convenient mesenteric vascular pedicle was brought without tension through the transverse mesocolon, passing behind the stomach to anastomose with the lower esophagus. An end-to-side jejuno-jejunostomy restored the bowel continuity at 40 cm from the esophago-jejunal anastomosis. When possible, a preexisting gastrostomy was preserved; otherwise, a new gastrostomy was fashioned [53, 59].
Recently, a technical modification of the technique has been proposed towards a more secure esophago-jejunal anastomosis (Fig. 50.11). It consists in the creation of an esophago-gastric stump using an articulated 5 mm laparoscopic Endo-GIA stapler; afterwards, a mechanical anastomosis between the esophago-gastric stump and the isoperistaltic jejunal roux loop is created [69].
Complications
The benefit/risk ratio of performing antireflux surgery even in patients with severe GERD is not clear.
Beyond the early post-operative complications (e.g., infection, bleeding, and perforation) that can happen after any gastrointestinal surgery, different complications directly related to the procedure of fundoplication may significantly impair or worsen quality of life.
Despite most long-term follow-up studies report successful outcome in more than 90% of children undergoing fundoplication, data on the true incidence of patients experiencing complications are very limited and derived from studies of poor methodological quality. Therefore, they would not seem to reflect what happens in real life. Indeed, complications are probably underreported in the literature as a result of the common tendency in clinical studies to publish positive results, and in this context, interpretation of results should consider that the great majority of papers are published by experienced and successful surgeons reporting their results of retrospective series [38]. Existing data show that complications are more common in children with underlying diseases as NI and previous esophageal atresia repair [70] that are, unfortunately, in exactly those conditions considered at high-risk for severe GERD accounting for the majority of indications for pediatric fundoplication [71].
Post-surgery issues can be due either to the persistence of symptoms prompting fundoplication, or to the side effects of surgery [72].
Former post-fundoplication complications may be related to a “bad diagnosis” in which the symptoms are incorrectly attributed to GERD. Guidelines on pediatric GERD and those specifically designed for the management of both children with NI and esophageal atresia recommend to objectively measure GERD before surgery [61, 73]. However, due to difficulties in obtaining an objective diagnosis of GERD, and due to the establish belief that most of symptoms experienced in these specific population are GERD-related, in clinical practice indication for surgery are often empirical and only based on center attitude and experience.
Upper gastrointestinal symptoms following fundoplication might be directly produced by the wrap that causes an antegrade obstruction that generates dysphagia, and/or a retrograde obstruction that produces inability to vent gas from the stomach and to vomiting that causes gas-bloat syndrome [72]. Moreover, fundoplication changes the morphology of the stomach by reducing its volume to create the wrap but it may also be potential cause of a variety of changes in gastric sensorimotor functions such as altered afferent input and development of visceral afferent hypersensitivity, gastrointestinal dysmotility, and changes in reflex pathways, including the gastric accommodation reflex and the emetic reflex [74, 75].
Mechanisms leading to disturbances in the gastric accommodation are not clear. Proximal gastric wall dysfunction, vagal injury, or mechanical effects have been reported as a cause of reduced gastric accommodation after surgery [76, 77].
Decreased gastric accommodation leads to impaired distribution of intragastric contents with the foods reaching and distending the distal stomach earlier than physiologically expected; reduced gastric compliance may lead to stimulation of visceral afferents producing visceral hypersensitivity and retching [78]. The rapid gastric emptying may also cause postprandial diarrhea, reactive hypoglycemia and dumping syndrome, reported in 30% of children after fundoplication [79].
Animal model showed that there is evidence that emetic sensitivity is increased post fundoplication [74]. Moreover, the operation may induce gastric dysrhythmia and loss of central inhibition of the gastric emetic reflex [80]. The activation of the emetic reflex leads to retching. Since fundoplication acts as a mechanical impediment to the final act of vomiting, gastric contents remain retained in the stomach, emetic reflex stimulus persists, and the retching continues [81].
Patients with fundoplication may experience gas-bloat syndrome that is characterized by abdominal bloating, postprandial fullness, inability to burp and vomit, and abdominal discomfort. It is more common in patients who have undergone complete laparoscopic Nissen fundoplication than partial fundoplication [82]. The inability to vent gas from the stomach due to the obstructive effect of the wrap may result in gastric distension with air that, if there is impaired accommodation of the fundus, may also lead in symptoms of retching and gagging. Venting gastrostomy between feeds will remove this accumulation of air, reduce overall gastric volume and help to prevent the resultant bloating [83].
Dysphagia is the most frequently reported postoperative complication [52]. Post-operative dysphagia is caused by outlet obstruction created by the wrap at the level of the esophagogastric junction. Early post-operative dysphagia generally resolves in the short term [84]. However, a subset of patient may develop long-term post-operative dysphagia that can mar otherwise successful GERD treatment [85, 86].
The risk of post-fundoplication dysphagia is significantly increased in patients with esophageal dysmotility since it may arise from insufficient esophageal peristaltic vigor to overcome the obstructive effect of the fundoplication [87]. Therefore, the integrity of esophageal motility is an important factor predicting outcomes following fundoplication. Preoperative and postoperative evaluation of the motility pattern on esophageal manometry could be useful to predict post-surgery outcome and to guide management of patients, even though existing data does not demonstrate a strong correlation between manometric changes and post-operative dysphagia [88, 89]. In this context, novel esophageal pressure-flow variables on high-resolution esophageal manometry with impedance demonstrates a high degree of prognostic value for prediction of postoperative new-onset dysphagia [86, 90].
Wrap failure due to a loose or disrupted wrap, or hiatal herniation, and recurrence of reflux, occurs in approximately 5–15% of children [47, 71]. Risk factors for fundoplication failure include younger age, preoperative hiatal hernia, postoperative retching, postoperative esophageal dilation; underlying disorder, such as esophageal atresia and NI, increased the risk of failure [71, 91, 92]. Wrap failure most occurs 1–3 years after fundoplication and is typically diagnosed due to recurrent GERD symptoms [71, 93].
Specific Patient Populations
Children with Neurological Impairment
Patients with NI are suffering from esophageal motor dysfunction directly related to central nervous system damage [94] that together with other predisposing condition, such as prolonged supine position and the increased intra-abdominal pressure secondary to spasticity, scoliosis or seizures, contribute to the risk of severe GERD [95]. In children with central nervous system disease, the incidence of GERD has been reported to be as high as 70% [61]. Even though children with NI account for the great majority requiring antireflux surgery in the pediatric surgical field, there have been very few studies that have evaluated the GERD of NI patients before surgery in relation to the outcome [96].
Pharyngo-esophageal motility dysfunctions in NI children may also produce a misdiagnosis of GERD and predispose to post-fundoplication complication.
For example, fundoplication is often pursued for NI patients with intractable aspiration with the idea they are at greater risk of aspirating gastroesophageal reflux contents. However, evidence failed to show a consistent benefit of fundoplication for the treatment of aspiration pneumonias, and, in some cases, aspiration can even worsen after fundoplication due to pooling of saliva and food above the wrap [64, 97, 98].
It has been reported that NI children undergoing feeding gastrostomies placement are at greater risk of development or worsening of GERD [99,100,101] and therefore “prophylactic” antireflux surgery has been historically advocated in this specific population. However, fundoplication is associated with a high occurrence rate post-operative morbidity (up to 50%) with a 1% to 3% mortality rate [74, 100,101,102,103]. Moreover, data on infants with NI who underwent fundoplication at the time of gastrostomy placement demonstrated that reflux-related hospitalizations were comparable with those of patients who underwent gastrostomy placement alone [104] and several studies evaluating the relationship between gastrostomy and GERD using pH/impedance monitoring failed to evidence a significant aggravation of GERD after placement of gastrostomy [99, 105]. Owing these data, ESPGHAN guidelines suggest that routine fundoplication at the time of gastrostomy would unnecessarily expose a large proportion of children with NI to antireflux surgery complications and recommends that it should not be performed [61].
ESPGHAN guidelines recommend that fundoplication be considered in cases of failure of optimized medical therapy for GERD in children with NI, and despite the overall limited predicting value of testing [106] extensive evaluation of GERD with endoscopy, contrast studies, gastric emptying studies, and pH-impedance should be always performed before performing surgery.
In general, it is important to highlight that, due to the considerable unpredictability of the surgery for GERD in NI children, surgeon should ensure that parents are fully informed as to the risks and benefits of the procedure.
Children with Esophageal Atresia
GERD is considered the most frequent gastrointestinal complication after surgical repair of esophageal atresia (EA) [73] responsible for several short- and long-term sequelae such as peptic complications (erosive esophagitis, gastric metaplasia, Barrett’s esophagus, and adenocarcinoma), anastomotic stricture formation and pulmonary complications (aspiration pneumonia, increased airway reactivity, chronic lung disease, and worsened tracheomalacia) [107,108,109,110]. Based on that, all EA patients are systematically treated with PPIs since surgical repair until 1 year of age, and most of them continue the treatment in the long term [73].
Fundoplication is performed in up to 45% of EA patients and almost all long-gap EA patients even if the indications for fundoplication are not clearly delineated as no controlled trial has been reported regarding the role of surgical management of GERD in patients with EA [110,111,112,113]. It is important to emphasize that, since virtually all EA survivors exhibit esophageal dysmotility [114], careful attention must be paid when fundoplication is considered because the outflow obstruction generated by the wrap is more likely to worsen the symptoms of esophageal dysmotility or produce new-onset of symptoms, in particular postoperative dysphagia (Fig. 50.12).
Current recommendations indicate to consider fundoplication in presence of poorly controlled GERD despite maximal PPI therapy, recurrent anastomotic strictures, especially in long-gap EA, long-term dependency on trans-pyloric feeding, acute life-threatening event [73].
It is noteworthy that data on prevalence of GERD demonstrated a high variability, ranging from 20% to 70% [115, 116], and that they are mainly obtained from studies using non-objective measures of GERD, such as the presence of symptoms [73]. However, although clinical suspicion has a main role in diagnosis GERD, it is important to highlight that esophageal symptoms in EA patients may be misinterpreted because of other comorbidities such us dysmotility, eosinophilic inflammation, anastomotic strictures, or other associated malformations [73].
Nevertheless, different studies recently published underestimate the true burden GERD and questioned about the widespread use of PPIs and the extensive indication for fundoplication [117,118,119,120]. Indeed, neither PPI treatment nor antireflux surgery have been found able to prevent the occurrence of esophageal histopathological complications that remain highly prevalent despite the extensive use of these treatments [117,118,119]. On the other hand, pressure-flow analysis on high-resolution impedance manometry revealed that abnormal peristalsis and impaired bolus transport are associated to histological changes [121]. These observations are raising the hypothesis that most EA patients might suffer from “retention esophagitis”, which is secondary to the impaired motility, rather than GERD-related esophagitis [120, 122].
GERD is also considered an important risk factor for recurrence of anastomotic strictures. Therefore, although its pathogenesis of is not fully understood [123], the occurrence of refractory anastomotic stricture represents a main indication for systematic PPI treatment and antireflux surgery [73]. However, different studies demonstrated that treatment with PPIs is unable to prevent anastomotic structuring in EA children questioning the real pathophysiological role of GERD in anastomotic stricture formation [124,125,126,127].
These findings coupled with the widely reported poor outcomes of fundoplication in EA patients [128, 129] require a necessary reconsideration of the extensive use of antireflux surgery in this specific population. It is established that fundoplication has an unquestioned value in improving quality of life in many EA children, but there must be a clear awareness that a significant portion of patients may experience worsening of their clinical condition. Although we are currently unable to predict which EA patient may benefit from antireflux surgery, a thorough multidisciplinary evaluation of the benefit-risk balance and extensive preoperative workup, incorporating the whole diagnostic armamentarium, should always be done before considering antireflux surgery in EA population.
Pediatric Intestinal Pseudo-Obstruction
Pediatric intestinal pseudo-obstruction (PIPO) is the most severe form of intestinal dysmotility in children.
Surgery and endoscopy are generally involved in outcome of PIPO patients: full thickness biopsy specimen to improve diagnosis, central catheter placement for parenteral nutrition support, decompressive intervention through enterostomies to manage abdominal distension, nutritional enterostomies to allow enteral autonomy, and major surgery for complication and/or for congenital association (malrotation) and intestinal transplantation. Patients often require surgical approach combined to medical and nutritional treatment to reach growth and development, to avoid disease complications and to improve quality of life.
A high complication rate after enterostomy formation and after surgical intervention is often detected; right indications and timing and specific technical expedients may be multidisciplinary decided and planned, individualizing the choices to each patient.
Pediatric Intestinal Pseudo-Obstruction: The Diagnostic and Therapeutic Role of Surgery
Pediatric intestinal pseudo-obstruction (PIPO) is the most severe form of intestinal dysmotility disorders in children, difficult to diagnose and treat. Most cases occur during neonatal period [130].
PIPO is characterized by an impairment of coordinated propulsive activity of the gastrointestinal tract, resulting in recurrent obstructive symptoms, without mechanical reasons.
PIPO diagnosis is a multistep path that relies on clinical picture and radiology (abdominal radiology, contrast study of small intestine, etc.), together with specialised tests (e.g., intestinal manometry) and surgery to obtain histopathology, in order to rule out the secondary causes of obstruction [131,132,133].
Therapeutic approaches are variable with high morbidity and mortality rate. Medical and surgical treatments are used to support the nutritional status, to prevent sepsis, and to restore the intestinal motility.
Despite the well-known certitude stating that in PIPO patient the surgical approach should be limited to biopsies (not systematically needed according to the ESPGHAN recommendations [131]) and eventually stoma creation, patients with PIPO frequently undergo repetitive and useless surgical procedures, often performed during newborn period also in non-specialized centre [130, 134, 135].
Unnecessary surgery exposes these patients to potential severe complications such increased risk of prolonged ileus, adhesions, leading to a possible progressive reduction of intestinal function up to the irreversible intestinal failure.
In all patients with suspect of PIPO, even if surgery represents one of the diagnostic and therapeutic tools, a dedicated trained medico-surgical multidisciplinary team should always discuss the indication.
Patients with evidence of PIPO from clinical and radiologic presentation should not be operated for diagnosis [135].
Surgical approach may be performed by laparotomy or laparoscopy depending on surgical expertise; laparoscopy may be challenging in newborn because of small operative space and dilation of the small bowel. Laparoscopy can be performed in children who had undergone previous laparotomy.
The indication for surgery allows two crucial points in the management of this complex disease:
-
1.
Diagnostic to exclude specific anatomical obstruction or congenital diseases (i.e., Hirschsprung’s disease);
-
2.
Therapeutic: enterostomy formation, treatment of associated malformations and resective surgery; intestinal transplantation.
Diagnostic Surgery
In newborns or children with persistent bowel obstruction without clear clinical, radiologic and/or manometric etiologic evidence, a diagnostic exploratory laparotomy or laparoscopy should be performed looking at the following steps.
Firstly, all gastrointestinal tracts should be carefully evaluated, from stomach to rectum to exclude causes of mechanical obstruction such as congenital stenosis or atresia/diaphragm, meconium ileus, duplication, abnormalities of intestinal rotation and fixation, the latter may be associated in 30% of cases of PIPO [131].
Secondly, in these patients without specific mechanical causes, serial full thickness biopsies from proximal jejunum to rectum should be performed for histopatologic analysis to assess nerve, muscle, Interstitial Cells of Cajal [136]. During surgery, extemporary frozen sections of rectal biopsies are mandatory to assess the presence of ganglion cells to exclude Hirschsprung’s disease.
Finally, as reported above, avoiding multiple surgeries is the goal of our practice; therefore, if patient is candidate to therapeutic surgery, (enterostomies) simultaneous biopsies should be considered as evidence and consensus statement recommendation of ESPGHAN proposed in 2018 [131].
Therapeutic Surgery
Therapeutic aims of surgery involve avoiding useless surgery and specific indications to required surgery:
-
(A)
Nutritional (enterostomy); decompressive (enterostomy).
-
(B)
Treatment of associated anomalies (malrotation); treatment of complications (stoma prolapse, post-surgical mechanical occlusion, colonic or small bowel volvulus).
-
(C)
Replacement (transplantation).
Enterostomies
Enterostomy is often performed as one of the first therapeutic measures. Bypassing the functional obstruction and obtaining digestive decompression, it may offer the chance to restore an intestinal transit allowing feeding and reducing parenteral nutrition (PN). The location of enterostomy is a matter of debate [135].
In 1985, Pitt et al. already stated that patients with chronic Intestinal pseudo-obstruction who receive total parenteral nutrition (TPN) at home and have a venting enterostomy could be safely managed for prolonged periods and require fewer hospitalizations for obstruction [137, 138].
Furthermore, Goulet et al. confirm that decompression ileostomy and colostomy represent one of the most useful tools to allow survival to adult life, together with careful treatment of urinary tract infections and bacterial overgrowth, and judicious use of PN [135].
Nutritional strategies tailored to the single patient enable one to reach enteral autonomy in several cases. As most of the patients requires PN to maintain normal growth and development, it is important to allow partial or total intestinal autonomy through gastrostomy and jejunostomy also like feeding routes with specialised feeds (e.g., hydrolysed protein feeds, amino acid formula, etc.). When PIPO is suspected, during explorative laparotomy, actual recommendations suggest gastrostomy insertion and ileostomy formation at the same time of full-thickness biopsies with the aim to minimize the number of procedures [131].
Gastrostomy and Proximal Jejunostomy
PIPO patients, because of severe pan-enteric motility troubles, experienced recurrent acute episodes of gastric outlet or duodenal functional obstruction, gastrectasis, preventing feeding and requiring decompression. Creating a gastrostomy, sometimes associated to a proximal jejunostomy (Fig. 50.13), is of great benefit because it avoids the recurrent placement of nasogastric tubes, allows the venting of the gastric content, decompresses the stomach, duodenum, and first jejunal loops, promoting a restoration of some degree of bowel movement with consequent enteral feeding tolerance. In these patients that experience prolonged PN, enteral feeding, also if minimal and for short periods, should be considered an indispensable therapeutic weapon because of its protective effect from TPN associated complications particularly on liver function (intestinal failure associated liver disease IFALD), avoiding or retarding liver deterioration with consequent possible indication for intestinal transplantation. Since enteral feeding should always be preferred than using PN, intragastric administration of feeding may be achieved by the gastric or jejunal tube as continuous or bolus enteral feeding. Percutaneous endoscopic gastrostomy (PEG) or gastro-jejunostomy (PEG-J) tube placement is easily achieved in these children and should be preferred as first choice because it avoid laparotomy and intestinal manipulation with increased risk of prolonged intestinal postoperative obstruction, adhesion formation, and surgical complications. Pull or push technique, according to centre expertise and patient’s characteristic and requiring, is recommended for endoscopic placement of gastrostomy or gastro-jejunostomy [139, 140].
When surgery is required, surgical gastrostomy should be considered during the same procedure.
Distal Ileostomy or Colostomy
ESPGHAN expert group recommends considering the formation of a decompressive enterostomy in all patients with PIPO on parenteral nutrition [131].
Furthermore, other authors underline as the enterostomies, such as ileostomies and/or colostomies, as distal as possible, represent the most logical approach to enable transit and to resume the obstructive episodes, obtaining some degree of intestinal autonomy with variable dependence from artificial nutrition [135].
However, despite stoma surgery is quite easy, in PIPO patients, it represents a challenge for several reasons.
Firstly, in most cases, the motor function is impaired throughout the intestine then, the choice of bowel segment for diversion is tricky, particularly in newborn and small children. A more proximal stoma such as a more distal stoma can have a worse effect on intestinal function related to high output fluid and electrolytes loss or persistence of obstruction, respectively. Even if ESPGHAN expert group does not recommend the use of scintigraphy for the measurement of small bowel and colon transit given that it has not been validated in the paediatric age, this investigation can add more information on the right and best site for enterostomy.
Second, the present knowledge in PIPO physiology highlights as the motor function of the bowel often is variable during the time alternating periods of occlusion to periods of restored transit therefore, a terminal enterostomy could be inaccurate as choice because it excludes a variable length of bowel which could retain some degree of active absorptive role during the periods of restored motor activity.
Finally, children with gastrointestinal motility disorders had high complication rate after enterostomy formation more as compared to children without motility disorders. Stoma prolapse, diversion colitis and electrolyte and fluid imbalance are the most common complications reported in these patients [141].
According to all reported above, a side-to-side Mikulicz or side-to-end Santulli enterostomy might be the choice better than terminal enterostomy (Figs. 50.14 and 50.15). Their advantages are represented by the restoration of intestinal transit, recruitment of the distal efferent bowel during the possible transient period of restored motility with increase of absorptive intestinal surface, and consequent possible reduction of the parenteral nutrition dependence.
Ideally, enterostomy formation should be done at the same time of intestinal biopsies.
Enterostomy represents a milestone in the management of PIPO patients so that about more or less of 50% of patients improve after enterostomy as to be weaned from PN; in patients in which clear improvement from ileostomy is observed, with PN weaning and at least 2 years follow up on enteral/oral feeding without exacerbations, total colectomy and ileorectal anastomosis with the Duhamel procedure could be considered [135].
Surgery of Associated Malformations or Complications
PIPO patients are exposed to variable risk of mechanical occlusion or postsurgical complications related to associated intestinal anomalies, chronic segmental bowel dilation, postoperative adhesions, and stoma prolapse.
During radiologic assessment in patients with suspected PIPO, upper gastrointestinal contrast study is mandatory to evaluate the configuration of the duodenal C- loop, the duodenojejunal flexure position and the position of the small bowel loops. If small bowel malrotation is confirmed, Ladd procedure should be performed at the same time of intestinal biopsies and enterostomies formation. In fact, conditions such as anomalies of intestinal fixation and rotation, observed in about 30% of PIPO, or segmental chronic colonic dilation and elongation related to prolonged stasis associated to motility troubles, may expose these patients to acute life-threatening complications such as midgut or segmental colonic volvulus, respectively.
Mechanical intestinal occlusion related to acute midgut or segmental colonic volvulus or postoperative adhesions may present as an acute episode of obstruction; in PIPO patients, this diagnosis may be challenging and delayed, because of misunderstanding with functional acute pseudo-obstructive episode. Mechanical occlusion may be suspected when occlusive symptoms and signs persist associated to clinical deterioration, despite correct conservative management by fluid and electrolytes balance and infusion, bowel venting manoeuvres (nasogastric tube, open gastrostomy and jejunostomy tubes, fasting, enterostomy tube placement), and intravenous antibiotic administration. Moreover, caution should be exercised during the occlusive episode, when abdominal distension and bowel loop dilation are overcoming the habitual dimension for the patient, on physical and plain radiographic examination [142]. In this situation, an abdominal CT scan coupled with contrast enema is helpful and recommended before surgery. In case of confirmed colonic volvulus, colonoscopy may be attempted before surgery (Fig. 50.16). If strongly suspected small bowel mechanical obstruction (i.e., volvulus, strangulation, kinking) or failed colonoscopy, an emergency laparotomy is mandatory.
Stoma prolapse is frequently observed in PIPO. While its pathogenesis is multifactorial, the variability and anarchy of the bowel movements probably play the main role.
The length of prolapsed bowel may be different even in a few hours observing few tens of centimetres into the ostomy bag. Signs and symptoms are not related to the length of the prolapsed intestine. Manual reduction or surgical correction of the prolapse can be frustrating with high recurrence rate so, the treatment should be carefully evaluated on a case-by-case basis, to avoid unnecessary surgery. If required, because of symptoms such as bleeding, obstruction, intestinal impairment, re-do stoma formation represent the best choice, avoiding, if possible, resection of the prolapsed bowel.
Transplantation
Intestinal transplantation, either isolated small bowel or multi-visceral, should be considered in patients presenting with life threatening TPN related complications such as intestinal failure associated liver disease (IFALD), or in patients whose intravenous access has become unreliable and precarious because of repeated sepsis and extensive thrombosis and finally, in patients with poor quality of life with high risk of morbidity and mortality related to frequent pseudo-obstructive episodes with difficult fluid electrolyte imbalance due to excessive fluid shifts necessitating repeated hospitalizations [131]. Transplant procedure varies according to the need of replacing liver and to the experience of the transplant surgical team.
Conclusions
Digestive Endoscopy and surgery represent challenging diagnostic and therapeutic tools in the armamentarium of the multidisciplinary dedicated medico-surgical team in PIPO patients. Surgical interventions should be minimised to avoid potential related complications (adhesions, prolonged paralytic ileus, etc.), which could worsen the outcome of these patients. Resective surgery (gastrectomy, colectomy, and small bowel resection) is often affected by failures, complications, and inadequate responses, compared to expectations [143]. An enterostomy is often performed as one of the first endoscopic or surgical therapeutic measures. Full thickness biopsies are mandatories to classify PIPO and they must be carried out at the same time of surgery for enterostomy creation. Enterostomies are very commonly used to decompress and reduce pseudo-obstructive events, to allow nutritional feeding through gastrostomy and jejunostomy reducing PN during the life of patients. Emergency laparotomy should be reserved only when a mechanical obstruction is assessed. Intestinal transplantation should be reserved only in selected cases with life threatening PN related complications or loss and unreliability of intravenous access.
When possible, endoscopy and surgery in children with suspected or known diagnosis of PIPO should be restricted to centres and practitioners with great experience in managing such patients with the aim to propose a structured approach.
Hirschsprung Disease
Hirschsprung’s Disease (HD), also known as “congenital aganglionic megacolon”, is a rare motor disorder of the gut, which is caused by a failure in the cranio-caudal migration of the neural crest cells during the 5–12 weeks of gestation, resulting in an aganglionic intestinal segment.
The incidence of HD is reported in about 1:5000 live births; the male to female ratio in recto-sigmoid disease is 4:1, but in longer segment disease is 1:1–2:1 [144, 145].
Intestinal aganglionosis extends proximally from the rectum for a variable length, with a recto-sigmoid involvement in about 80% of patients; a long-segment type in 15–20% of cases and a total colonic aganglionosis (TCA) in approximately 5% of subjects. In rare cases, a total intestinal aganglionosis with absent ganglion cells from the rectum to the duodenum is described. In ultra-short HD type, the aganglionic tract is limited to the distal 2–3 cm of the rectum [146, 147].
Antenatal suspicion and/or diagnosis of HD is rare. Most patients are diagnosed in neonatal period or even later, due to the variability in clinical presentation, which is dependent on the length of the aganglionosis.
Genetics
HD occurs as an isolated condition in 70% of the cases, associated with additional congenital anomalies in 18% of patients (cardiac defects 8%, genitourinary 6%, gastrointestinal abnormalities 4%), and as a part of a genetic syndrome in up to 12% of cases (i.e., Down Syndrome, Waardenburg syndrome, Mowat-Wilson syndrome, MEN type 2A) [146].
Several genes have been found to be involved in HD (i.e., GDNF, NRTN, SOX10, EDNRB, EDN3 ECE1, ZFHX1B, PHOX2B, KIAA1279, TCF4, L1CAM, and IKBKAP) [148, 149].
The major susceptibility gene is proto-oncogene RET, which is implicated in about 50% of family forms, in 40–45% of sporadic cases, and in a higher percentage of long than of short type HD (76% vs. 32%) [150,151,152,153,154].
More than 100 different mutations have been described in the RET gene [150], some of which are also associated with the development of Multiple Endocrine Neoplasia type 2A (MEN 2A), a cancer syndrome characterized by medullary thyroid carcinoma, phaeochromocytoma of the adrenal glands, and hyperplasia of the parathyroid glands [155].
Therefore, ERNICA guidelines for HD suggest, in non-syndromic cases, to offer referral to parents or patients who wish to have a genetic screening and recommend genetic consultation for subjects with a family history of HD, where the incidence of RET mutations is even higher. In syndromic types, the genetic screening must be associated with the specific gene of the syndromic phenotype [156].
Clinical Presentation
HD should be suspected in any newborn with intestinal obstruction, in any infant and child with refractory severe constipation, chronic abdominal distention and history of delayed or failed passage of meconium within the first 24–48 h of life. This latter is the cardinal clinical feature in about 80–90% of infants with HD but also in 30–40% of healthy children and in 30–35% of preemies [144].
Intestinal obstruction symptoms (bilious vomiting, abdominal distension, and constipation), spontaneous intestinal perforation or episodes of acute “toxic” enterocolitis are typical findings during the neonatal period in the recto-sigmoid or in longer types of HD [150, 157,158,159].
Explosive bowel movements caused by functional colonic obstruction and enterocolitis-related diarrhoea rather than constipation are possible symptoms in infants with HD [160].
Refractory constipation, frequently associated with abdominal distension and failure to thrive, seems to be the only symptom in the ultra-short form and in older children. Rectal examination usually reveals a tight anal sphincter and explosive discharge of stool and gas.
Diagnosis
Tests available for diagnosing HD include manometric, radiological, and histological studies.
Anorectal manometry assesses the correct innervation of the internal anal sphincter (IAS) eliciting the recto-anal inhibitory reflex (RAIR) via the myenteric plexus. RAIR is a relaxation response in the IAS, namely a pressure drop of at least 25% in the anal canal following rectal distension. The absence of RAIR is indicative of HD [161].
Contrast enema is a useful screening test for a pre-operative morphological evaluation of the colon. The finding of the pathognomonic sign of “transition zone” (Fig. 50.17), a funnel-shaped segment between the narrowed aganglionic rectum and the proximal normally innervated segment, may aid in surgical procedure planning since the location of the radiographic transition zone correlates with the level of aganglionosis in 63% to 90% of cases [162,163,164].
Unfortunately, the transition zone may not be detected in neonates, because of insufficient time to develop the dilation, or in infant treated by frequent saline rectal irrigations.
Rectal suction or full-thickness biopsy remains the gold standard test in the diagnostic workup of HD. The tissue samples should be taken a minimum of 2 cm above the dentate line to avoid the physiologic aganglionic/hypoganglionic zone of the distal rectum [165], specimens should be at least 3 mm diameter and one-third of them should comprise submucosa [166, 167].
The absence of ganglion cells confirms the clinical and radiological suspicion of HD.
Differential diagnosis may consider meconium ileus secondary to cystic fibrosis, gastrointestinal malformations (intestinal atresia, malrotation, duplication cysts), multiple endocrine neoplasia type 2A (MEN 2A), intestinal neuronal dysplasia, meconium plug syndrome, small left colon syndrome, chronic intestinal pseudo-obstruction, and hypothyroidism [146].
Surgical Techniques
The aim of treatment in HD is the resection of the aganglionic segment, the anastomosis to the anus of the normally innervated bowel, and the preservation of the anal sphincter function.
Historically, colostomy was performed at diagnosis of HD and colonic pull-through was scheduled 6–12 months later. Thanks to the improvement of diagnostic and surgical techniques, surgery shifted from multistage to single stage.
Temporary stoma is indicated in presence of intestinal perforation or acute enterocolitis unresponsive to non-operative treatment and when rectal washouts are not effective to decompress the bowel [168].
In emergency settings, the level of the stoma should be proximal to the site of perforation or empirical in the distal ileum. In elective conditions, the stoma may be performed above the transitional zone (also known as “leveling stoma”), in a normal neuronal pattern bowel segment, detected by peri-operative biopsies [169].
According to ERNICA HD guidelines, the pre-operative management includes: 1–3 times per day saline rectal irrigations to decompress the bowel until the definitive pull-through operation; contrast enema, that may help to define the level of aganglionosis with possible identification of the transition zone, although it does not replace the need for histological assessment; pre-operative one dose of broad-spectrum intravenous antibiotics, which should be continued for 24–48 h post-operatively [156].
Different surgical options are available using an abdominal and/or trans-anal approach and the choice of procedure is usually based on the training and experience of the surgeon.
Full-thickness biopsies should be performed intra-operatively to define the correct level of aganglionosis and identify the normally innervated colon to bring down to the anal canal for anastomosis [156, 170].
Swenson Procedure
The Swenson procedure, first performed in 1948, was the original pull-through procedure used to treat HD. The technique consists of a deep pelvic dissection with mobilization of rectum and left colon to bring normal bowel down the perineum. The rectum is intussuscepted through the anus and an incision is made 1.5 cm above the dentate line of the anal canal, in the anterior zone of the circumference, in order to preserve faecal continence and facilitate voluntary bowel movements. The intussuscepted colon is pulled through until the correct level is visualized. An anastomosis between pulled-through ganglionic colon and anal canal is performed obliquely outside the anus as the bowel is divided and removed (Fig. 50.18). Finally, the anastomosis is returned to the pelvis [171, 172].
Duhamel Procedure
The Duhamel procedure, described in 1956, requires much less pelvic dissection than the Swenson procedure with a lower risk of incontinence. The aganglionic bowel is resected down the rectum that is maintained in situ. The ganglionic bowel is brought down to the level of anal canal through a bloodless retro-rectal space between rectum and sacrum. A side-to-side anastomosis between the anterior aganglionic rectal stump and the posterior pulled-through ganglionic bowel is performed using a linear stapler which simultaneously joins the two segments and divides the common wall between them to create a single lumen (Fig. 50.19) [173].
Soave Procedure
The endorectal pull-through operation was first described by Soave in 1964 and later modified by Boley. An accurate trans-abdominal submucosal dissection of the aganglionic segment of the colon is extended down to the anal canal, leaving the muscular coat of the rectum intact, avoiding lesions of pelvic innervation. The ganglionic bowel is pulled through the muscular cuff and anastomosed to the anal canal about 1 cm above the dentate line. The original procedure left a 5- to 10-cm length of the pull-through colon hanging out through the anus and the final anastomosis had to be created several weeks later [174].
Boley modified this procedure, performing a single stage operation with primary anastomosis at the anus with or without splitting of the aganglionic muscular cuff (Fig. 50.20) [175].
Transanal Endorectal Pull-Through
The transanal endorectal pull-through was introduced by De la Torre-Mondragon and Ortega Salgado in 1998, as a modification of the Soave procedure [176, 177].
This technique consists of a totally transanal endorectal pull-through without any laparotomic or laparoscopic mobilization.
As first step, the rectal mucosal layer is incised 0.5–1 cm above the dentate line and a rectal mucosal cylinder is dissected as far as the peritoneal reflexion. Multiple 5-0 silk traction sutures are placed in the mucosa to facilitate its separation from the muscular wall (Fig. 50.21).
The division of the muscular rectal wall is continued circumferentially, freeing the intra-abdominal colon from the muscular sleeve (Fig. 50.22). A posterior myotomy of the muscular sleeve is made above the place where the anastomotic line should be created (Fig. 50.23).
Once the muscular sleeve is prepared and liberated, the rectum is pulled down and perirectal tissues are easily exposed and the mesenteric vessels are dissected, tied, and divided. Thus, the colon is pulled through the rectal muscular sleeve onto the anus (Fig. 50.24).
During this step, full-thickness biopsy specimens of the colon are examined through frozen sections to assure normoganglionic level. The aganglionic colon is resected, and a primary anastomosis is made between the normally ganglionic colon and the rectal mucosa.
Laparoscopic- and Robotic-Assisted Colon Pull-Through
Laparoscopic-assisted colon pull-through procedure exploits the well-known advantages of laparoscopy, such as less postoperative pain, quicker recovery, less adhesive bowel obstruction and wound complications, better cosmetic results and, furthermore, gives the opportunity to perform intraoperative multiple biopsies, visualizes the pulled through colon, and prevents twisting of the bowel.
The sigmoid colon and the rectum can be mobilized laparoscopically; a submucosal sleeve is crafted trans-anally to meet the dissection from above. The ganglionic colon is then pulled down in continuity, divided above the transition zone and anastomosed to the anal mucosa 5 to 10 mm above the dentate line [178].
During the last decade, the robotic assisted pull-through procedure has been used to treat infants, even younger than 12 months of life, and children suffering from recto-sigmoid HD, long segment HD and TCA [179,180,181].
Some potential advantages of robotic surgery include greater surgical precision, increased range of motion, improved dexterity, enhanced visualization, and better access to hard-to-reach areas.
Four trocars are needed to perform the intraoperative seromuscular levelling biopsies and to mobilize the rectum down to the anal canal with an intracorporeal endorectal cranial dissection; the rectal cuff is divided posteriorly, the previously isolated colon is then pulled-through and a colo-anal anastomosis is achieved at the pectinate line by an endoanal approach.
The first results are encouraging in terms of intra−/post-surgical complications and continence outcomes.
Future studies are needed to compare the long-term data of this approach with the open and laparoscopic techniques [179].
Total Colonic Aganglionosis (TCA)
Surgical treatment for TCA is a challenge for surgeons (Fig. 50.25). To this aim, various techniques have been performed, including a long longitudinal side to side anastomosis between the aganglionic bowel and the pulled-through ganglionic healthy bowel (Lester Martin procedure) [182]; a longitudinal side-to-side ileocolostomy between the normal ileum and the aganglionic ascending colon forming a colonic patch graft (Kimura procedure) [183] and proctocolectomy with J pouch-ileoanal anastomosis [184,185,186].
Ultra-Short HD
The ultra-short form of HD is an aganglionic segment of less than 2 to 3 cm histologically characterized by the absence of both hypertrophic nerves and abnormal cholinesterase staining [187].
The treatment of ultrashort-segment HD is controversial, so that different therapies, such as intrasphincteric botulinum toxin injections, simple anal sphincter myectomy and excision of the aganglionic segment with bowel pull-through, are taken into consideration [188, 189].
Early Postoperative Management
ERNICA guidelines recommend to adopt the Enhanced Recovery After Surgery (ERAS) protocols in paediatric colorectal surgery to improve surgical outcomes and efficiency of care [156].
Items of ERAS include use of minimally invasive surgical techniques, opioid-sparing analgesia, early post-surgical re-feeding, and judicious use of drains and catheters. ERAS pathways have demonstrated to reduce length of stay and complication rates, with an increment of patient satisfaction [190].
Early Post-Surgical Complications
Anastomotic leak and cuff abscess are rare early post-surgical complications, reported in 1–10% and in 5% of cases, respectively [191,192,193,194].
The risk is increased in presence of tension or ischemia of the anastomosis, poor nutritional status, steroid usage, and residual aganglionosis. A water-soluble contrast enema may be useful to make a diagnosis. Treatment may include surgical exploration, diverting colostomy, and revision of anastomosis [146].
Anastomotic strictures are a potential complication after pull-through surgery with an incidence up to 10.6% (range: 0–18.9%) [195].
Predisposing factors include ischemia, anastomotic leakage, and anastomotic tension. The risk is lower after Duhamel procedure since the colo-rectal anastomosis is wider. Calibration of the coloanal anastomosis is advisable at around 2–3 weeks after pull-through surgery, while daily anal dilatations are suitable in case of stricture [146].
Long-Term Post-Surgical Complications
Despite surgical techniques and medical care have improved over recent years, severe constipation (9–40%), faecal incontinence (FI; >8–74%) or Hirschsprung-Associated Enterocolitis (HAEC) (25–37%) can persist after pull through surgery in a long-term outcome [169, 196,197,198,199,200,201,202,203]. According to ERNICA guidelines for HD, a careful re-evaluation of these patients is mandatory to ensure a functional improvement and to prevent a psycho-social unrest [156].
The first step comprises clinical and nutritional check with full survey of the stooling pattern, dietary history, and development.
In persistent post-operative constipation or in case of obstructive symptoms, anatomical (mechanical or histological) and functional aetiologies should be considered [169].
Rectal examination and contrast enema are required in Soave and in De la Torre-Mondragon procedures to rule out mechanical causes, such as anastomotic stricture, rolled or stenotic muscle cuff (Fig. 50.26) and twisted pull-through; in Duhamel technique occurrence of rectal spur.
Histological review of the proximal margins of the originally resected bowel and/or repetition of rectal biopsies are necessary to exclude an aganglionic residual segment or a pulled-through transition zone.
In accordance with the findings, anal dilations for anastomotic stricture or redo surgery (section of rectal spur; surgical revision of cuff stenosis or bowel torsion; redo pull through in twisted colon and in residual aganglionosis or in incomplete resection of transition zone) should be considered [203, 204]. If no mechanical or histological complications are documented, botulinum toxin can be administered to relax the internal anal sphincter and facilitate the passage of stool [205, 206].
Bowel management programme is recommended to non-responders after repeated (>3) botulinum toxin injections. There are various management options available (retrograde enemas or antegrade continence colonic irrigations through appendicostomy or cecostomy) which can be suggested by the patient.
Faecal incontinence (FI) is another problem after pull-through surgery, that implies evaluation of the anorectum and colon to distinguish between overflow or retentive and non-retentive type.
Overflow or retentive FI may depend on mechanical obstruction with faecal impaction and overflow of liquid stool; in other cases, hyperperistalsis of the pulled-through bowel determines recurrent soiling, despite normal sphincter function.
Non-retentive or true FI is secondary to anal sphincter injuries or abnormal rectal sensation.
A careful clinical inspection of the anal canal under anaesthesia is mandatory to exclude anatomical causes of retention and to document the site of the anastomosis in relation to the dentate line and its circumferential integrity, necessary to distinguish between gas, liquid, or solid stool [207].
A complete assessment of anal sphincters includes endoanal ultrasonography, which aids in the diagnosis of anal sphincter injuries, and anorectal manometry, which offers useful data about rectal sensation, pelvic floor dyssynergia, and anal pressures [208, 209].
Intestinal peristalsis (hypo- or hypermotility) and dilatation of pulled colon should be evaluated by motility tests (colonic manometry, colonic scintigraphy, and radiopaque markers) and a morphological study (contrast enema), respectively.
Successful management of FI depends on a clear understanding of the underlying problem. Thus, laxatives should be administered in case of intact anal canal, dilated colon and constipation (hypomotility colon); constipating diet, loperamide and bulking agents (pectin, psyllium) are useful for patients without colonic dilatation and a tendency to lose stools (hypermotility colon); a bowel management programme should be proposed in non-retentive FI to completely empty the colon; biofeedback training may be effective in pelvic dyssynergia [156].
Enterostomy remains a rescue option if the other treatments fail to control symptoms.
Hirschsprung-associated enterocolitis (HAEC) is a common and sometimes life-threatening complication of HD. Long-segment disease, older age at radical surgery, Down’s syndromee and previous episodes of HAEC are recognised predisposing factors for recurrent HAEC [210].
The aetiology is probably multifactorial; alterations in the intestinal barrier, dysbiosis of the intestinal microbiota, bacterial translocation and impaired gastrointestinal mucosal immunity can contribute to the development of this severe condition [211].
Clinical presentation can include fever, abdominal distension, explosive foul-smelling bloody diarrhoea, lethargy; on this occurrence the abdominal X-rays usually show multiple air–fluid levels, dilated loops of bowel, and pneumatosis (Fig. 50.27a–c).
In acute forms, intravenous fluid resuscitation, broad-spectrum antibiotics, and saline rectal washouts to decompress the bowel are recommended [212].
The risk of HAEC may be decreased by using preventive measures such as routine irrigations or/and chronic administration of metronidazole; intra-sphincteric botulinum toxin injection is a valid and minimally invasive therapeutic option, that reduces the incidence of HAEC in 62–89% of HD patients [205, 213,214,215,216,217,218].
Redo surgery (i.e., posterior myotomy or redo pull-through according to the underlying causes) is indicated in case of mechanical obstruction.
Surgical Procedures and Outcome
In literature, no agreement has been reached about the optimal surgical approach to treat HD. Heterogeneity in the results depends on various parameters such as type of HD, presence of a colostomy, operation timing, complexity of the operation and experience of the surgeon.
Trans-abdominal endorectal pull through techniques spare the perirectal innervation, with a low rate of incontinence and sexual problems. Trans-anal endorectal pull through adds the typical advantages of minimally invasive procedures even if the anal sphincter may be overstretched during anal traction, leading to permanent incontinence/soiling. However, manometric comparison between perineal and abdominal approach shows that the postoperative sphincter function does not decrease in patients undergoing trans-anal endorectal pull through [219, 220].
Likewise, the occurrence of incontinence after the Duhamel operation is like that after the trans-anal endorectal pull through intervention, probably due to minimal pelvic dissection that avoids autonomic nerve damage [221].
As regards constipation, there is no significant difference between the Soave group and the trans-anal endorectal pull through population [222] and between Soave and Swenson operation, notwithstanding the incomplete excision of the aganglionic rectal wall in the first of the two [223, 224].
Chatoorgoon et al. reported a high risk of constipation in patients with a mega Duhamel pouch [225], while Widyasari et al. documented a higher constipation rate in the Soave respect to the Duhamel group, as the latter offers the advantage of a wide anastomosis [226].
A systematic meta-analysis comparing Duhamel with transanal endorectal pull-through procedures in infants and children testified similar results regarding rate of postoperative fecal incontinence and operation time; anyway, Duhamel procedure seems to be associated with longer hospital stay and lower rate of enterocolitis [221].
All the techniques can be performed via laparoscopic surgery, which results in minor trauma, smaller amounts of blood loss, lower intraperitoneal contamination, and less intestinal adhesions [221].
In any case, in a long-term follow up, more than 90% of HD affected individuals relate satisfactory outcomes and approximately only 1% suffers from debilitating incontinence requiring a permanent colostomy [227].
Subjects with chromosomal abnormalities and syndromes or with TCA, have a worse prognosis [228].
Conclusions
HD is a rare, congenital, and complex motility disorder caused by a lack of ganglion cells in the enteric neural plexuses of the intestine. The treatment is primarily surgical and aims at the resection of the aganglionic segment and at a re-anastomosis with ganglionated bowel. Different surgical options are available and ensure good clinical results in most patients. In any case, a follow up to adulthood, within the context of an interdisciplinary care team, is recommended because of the risk of recurrent enterocolitis, persistent constipation, or faecal incontinence.
Abbreviations
- CC:
-
Chicago classification
- DES:
-
Diffuse esophageal spasm
- EA:
-
Esophageal atresia
- EGJ:
-
Esophagogastric junction
- ERAS:
-
Enhanced recovery after surgery
- ESPGHAN:
-
European Society for Pediatric Gastroenterology, Hepatology, and Nutrition
- FI:
-
Faecal incontinence
- GER:
-
Gastroesophageal reflux
- GERD:
-
Gastroesophageal reflux disease
- HAEC:
-
Hirschsprung-associated enterocolitis
- HD:
-
Hirschsprung’s disease
- HRM:
-
High-resolution manometry
- IAS:
-
Internal anal sphincter
- IFALD:
-
Intestinal failure associated liver disease
- JH:
-
Jackhammer esophagus
- LES:
-
Lower esophageal sphincter
- LHM:
-
Laparoscopic Heller’s myotomy
- MEN2A:
-
Multiple Endocrine Neoplasia type 2A
- NASPGHAN:
-
North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition
- NI:
-
Neurological impairment
- PEG:
-
Percutaneous endoscopic gastrostomy
- PEG-J:
-
Percutaneous endoscopic gastro-jejunostomy
- PIPO:
-
Pediatric intestinal pseudo-obstruction
- PN:
-
Parenteral nutrition
- POEM:
-
Peroral endoscopic myotomy
- PPI:
-
Proton pump inhibitor
- RAIR:
-
Recto-anal inhibitory reflex
- TCA:
-
Total colonic aganglionosis
- TLESR:
-
Transient Lower esophageal sphincter relaxation
- TPN:
-
Total parenteral nutrition
References
Cotton Peter B. Fading boundary between gastroenterology and surgery. J Gastroenterol Hepatol. 2000;15:G34–7.
Fisichella PM, Raz D, Palazzo F, et al. Clinical, radiological, and manometric profile in 145 patients with untreated achalasia. World J Surg. 2008;32:1974–9.
Hallal C, Kieling CO, Nunes DL, et al. Diagnosis, misdiagnosis, and associated diseases of achalasia in children and adolescents: a twelve-year single center experience. Pediatr Surg Int. 2012;28:1211–7.
Franklin AL. Childhood achalasia: a comprehensive review of disease, diagnosis and therapeutic management. World J Gastrointest Endosc. 2014;6:105.
Bredenoord AJ, Fox M, Kahrilas PJ, et al. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil. 2012;24(Suppl 1):57–65.
Vaezi MF, Pandolfino JE, Vela MF. ACG clinical guideline: diagnosis and management of achalasia. Am J Gastroenterol. 2013;108:1238–49.
Petrosyan M, Khalafallah AM, Guzzetta PC, et al. Surgical management of esophageal achalasia: evolution of an institutional approach to minimally invasive repair. J Pediatr Surg. 2016;51:1619–22.
Repici A, Fuccio L, Maselli R, et al. GERD after per-oral endoscopic myotomy as compared with Heller’s myotomy with fundoplication: a systematic review with meta-analysis. Gastrointest Endosc. 2018;87:934–943.e18.
Sharp KW, Khaitan L, Scholz S, et al. 100 consecutive minimally invasive Heller myotomies: lessons learned. Ann Surg. 2002;235(5):631–9.
Kethman WC, Thorson CM, Sinclair TJ, et al. Initial experience with peroral endoscopic myotomy for treatment of achalasia in children. J Pediatr Surg. 2018;53:1532–6.
Torquati A, Richards WO, Holzman MD, et al. Laparoscopic myotomy for achalasia predictors of successful outcome after 200 cases. Ann Surg. 2006;243(5):587–93.
Richards WO, Torquati A, Holzman MD, et al. Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia a prospective randomized double-blind clinical trial. Ann Surg. 2004;240:405–15.
Oelschlager BK, Chang L, Pellegrini CA. Improved outcome after extended gastric myotomy for achalasia. Arch Surg. 2003;138(5):490–7.
Patti MG, Feo CV, Arcerito M, et al. Effects of previous treatment on results of laparoscopic Heller myotomy for achalasia. Dig Dis Sci. 1999;44(11):2270–6.
Horgan S, Galvani C, Gorodner MV, et al. Robotic-assisted Heller myotomy versus laparoscopic Heller myotomy for the treatment of esophageal achalasia: multicenter study. J Gastrointest Surg. 2005;9:1020–30.
Galvani C, Gorodner MV, Moser F, et al. Laparoscopic Heller myotomy for achalasia facilitated by robotic assistance. Surg Endosc. 2006;20:1105–12.
Huffmanm LC, Pandalai PK, Boulton BJ, et al. Robotic Heller myotomy: a safe operation with higher postoperative quality-of-life indices. Surgery. 2007;142:613–20.
Melvin WS, Dundon JM, Talamini M, et al. Computer-enhanced robotic telesurgery minimizes esophageal perforation during Heller myotomy. Surgery. 2005;138:553–9.
Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010;42:265–71.
Pasricha PJ, Hawari R, Ahmed I, et al. Submucosal endoscopic esophageal myotomy: a novel experimental approach for the treatment of achalasia. Endoscopy. 2007;39(9):761–4.
Caldaro T, Familiari P, Romeo EF, et al. Treatment of esophageal achalasia in children: today and tomorrow. J Pediatr Surg. 2015;50(5):726–30.
Li C, Tan Y, Wang X, et al. Peroral endoscopic myotomy for treatment of achalasia in children and adolescents. J Pediatr Surg. 2015;50:201–5.
Chen WF, Li QL, Zhou PH, et al. Long-term outcomes of peroral endoscopic myotomy for achalasia in pediatric patients: a prospective, single-center study. Gastrointest Endosc. 2015;81:91–100.
Ngamruengphong S, Inoue H, Ujiki MB, et al. Efficacy and safety of peroral endoscopic myotomy for treatment of achalasia after failed Heller myotomy. Clin Gastroenterol Hepatol. 2017;15:1531–1537.e3.
Zhong C, Tan S, Huang S. Clinical outcomes of peroral endoscopic myotomy for achalasia in children: a systematic review and meta- analysis. Dis Esophagus. 2021;34:1–11.
Askegard-Giesmann JR, Grams JM, Hanna AM, et al. Minimally invasive Heller’s myotomy in children: safe and effective. J Pediatr Surg. 2009;44:909–11.
Bonatti H, Hinder RA, Klocker J, et al. Long-term results of laparoscopic Heller myotomy with partial fundoplication for the treatment of achalasia. Am J Surg. 2005;190:883–7.
Pacilli M, Davenport M. Results of laparoscopic Heller’s myotomy for achalasia in children: a systematic review of the literature. J Laparoendosc Adv Surg Tech A. 2017;27:82–90.
Di Corpo M, Farrell TM, Patti MG. Laparoscopic Heller myotomy: a funduplication is necessary to control gastroesophageal reflux. J Laparoendosc Adv Surg Tech A. 2019;29(6):721–5.
Inoue H, Shiwaku H, Kobayashi Y, et al. Statement for gastroesophageal reflux disease after peroral endoscopic myotomy from an international multicenter experience. Esophagus. 2020;17:3–10.
Hungness ES, Teitelbaum EN, Santos BF, et al. Comparison of perioperative outcomes between peroral esophageal myotomy (POEM) and laparoscopic heller myotomy. J Gastrointest Surg. 2013;17:228–35.
Kumbhari V, Tieu A, Onimaru M, et al. Peroral endoscopic myotomy (POEM) vs laparoscopic Heller myotomy (LHM) for the treatment of Type III achalasia in 75 patients: a multicenter comparative study. Endosc Int Open. 2015;3:E195–201.
Eckardt AJ, Eckardt VF. Treatment and surveillance strategies in achalasia: an update. Nat Rev Gastroenterol Hepatol. 2011;8:311–9.
Akintoye E, Kumar N, Obaitan I, et al. Peroral endoscopic myotomy: a meta-analysis. Endoscopy. 2016;48:1059–68.
Haito-Chavez Y, Inoue H, Beard KW, et al. Comprehensive analysis of adverse events associated with per oral endoscopic myotomy in 1826 patients: an international multicenter study. Am J Gastroenterol. 2017;112:1267–76.
Lasser MS, Liao JG, Burd RS. National trends in the use of antireflux procedures for children. Pediatrics. 2006;118(5):1828–35.
Jancelewicz T, Lopez ME, Downard CD, et al. Surgical management of gastroesophageal reflux disease (GERD) in children: a systematic review. J Pediatr Surg. 2017;52(8):1228–38.
Di Lorenzo C, Orenstein S. Fundoplication: friend or foe? J Pediatr Gastroenterol Nutr. 2002;34(2):117–24.
Rosen R, Vandenplas Y, Singendonk M, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66(3):516–54.
NICE Guideline. Gastro-oesophageal reflux disease in in children and young people: diagnosis and young people: diagnosis and management. London: National Institute for Health and Care Excellence (NICE); 2019.
Khan F, Maradey-Romero C, Ganocy S, et al. Utilisation of surgical fundoplication for patients with gastro-oesophageal reflux disease in the USA has declined rapidly between 2009 and 2013. Aliment Pharmacol Ther. 2016;43(11):1124–31.
Maassel NL, Shaughnessy MP, Solomon DG, et al. Trends in fundoplication volume for pediatric gastroesophageal reflux disease. J Pediatr Surg. 2021;56(9):1495–9.
Johnson DG. The past and present of antireflux surgery in children. Am J Surg. 2000;180(5):377–81.
Fox D, Morrato E, Campagna EJ, et al. Outcomes of laparoscopic versus open fundoplication in children’s hospitals: 2005–2008. Pediatrics. 2011;127:872–80.
Gilna GP, Saberi RA, Baez AC, et al. Nationwide outcomes and readmission after pediatric laparoscopic and open fundoplication. J Laparoendosc Adv Surg Tech A. 2021;31(12):1389–96.
Kane TD, Brown MF, Chen MK. Position paper on laparoscopic antireflux operations in infants and children for gastroesophageal reflux disease. J Pediatr Surg. 2009;44:1034–40.
Rothenberg SS. Two decades of experience with laparoscopic Nissen fundoplication in infants and children: a critical evaluation of indications, technique, and Results. J Laparoendosc Adv Surg Tech A. 2013;23(9):791–4.
Knatten CK, Fyhn TJ, Edwin B, et al. Thirty-day outcome in children randomized to open and laparoscopic Nissen fundoplication. J Pediatr Surg. 2012;47(11):1990–6.
Fyhn TJ, Knatten CK, Edwin B, et al. Randomized controlled trial of laparoscopic and open Nissen fundoplication in children. Ann Surg. 2015;261(6):1061–7.
Pacilli M, Eaton S, Mchoney M, et al. Four year follow-up of a randomised controlled trial comparing open and laparoscopic Nissen fundoplication in children. Arch Dis Child. 2014;99:516–21.
Siddiqui MRS, Abdulaal Y, Nisar A, et al. A meta-analysis of outcomes after open and laparoscopic Nissen’s fundoplication for gastro-oesophageal reflux disease in children. Pediatr Surg Int. 2011;27:359–66.
Kubiak R, Andrews J, Grant HW. Long-term outcome of laparoscopic Nissen fundoplication compared with laparoscopic Thal fundoplication in children: a prospective, randomized study. Ann Surg. 2011;253(1):44–9.
Bianchi A. Total esophagogastric dissociation: an alternative approach. J Pediatr Surg. 1997;32(9):1291–4.
Morabito A, Lall A, Piccolo R, et al. Total esophagogastric dissociation: 10 years’ review. J Pediatr Surg. 2006;41:919–22.
Gatti C, di Abriola GF, Villa M. Esophagogastric dissociation versus fundoplication: which is best for severely neurologically impaired children? J Pediatr Surg. 2001;36(5):677–80.
Lansdale N, McNiff M, Morecroft J, et al. Long-term and “patient-reported” outcomes of total esophagogastric dissociation versus laparoscopic fundoplication for gastroesophageal reflux disease in the severely neurodisabled child. J Pediatr Surg. 2015;50(11):1828–32.
Peters RT, Goh YL, Veitch JM, et al. Morbidity and mortality in total esophagogastric dissociation: a systematic review. J Pediatr Surg. 2013;48(4):707–12.
Gottrand M, Michaud L, Guimber D, et al. Barrett esophagus and esophagojejunal anastomotic stenosis as complications of esophagogastric disconnection in children with esophageal atresia. J Pediatr Gastroenterol Nutr. 2013;57:93–5.
Lall A, Morabito A, Dall’Oglio L, et al. Total oesophagogastric dissociation: experience in 2 centres. J Pediatr Surg. 2006;41(2):342–6.
Madre C, Serhal L, Michaud L, et al. Prolonged enteral feeding is often required to avoid long-term nutritional and metabolic complications after esophagogastric dissociation. J Pediatr Gastroenterol Nutr. 2010;50:280–6.
Romano C, van Wynckel M, Hulst J, et al. European Society for Paediatric Gastroenterology, Hepatology and Nutrition guidelines for the evaluation and treatment of gastrointestinal and nutritional complications in children with neurological impairment. J Pediatr Gastroenterol Nutr. 2017;65:242–64.
McCann C, Cullis PS, McCabe AJ, et al. Major complications of jejunal feeding in children. J Pediatr Surg. 2019;52(2):258–62.
Livingston RH, Shawyer AC, Rosenbaum PL, et al. Fundoplication and gastrostomy versus percutaneous gastrojejunos-tomy for gastroesophageal reflux in children with neurologic impairment: a systematic review and meta-analysis. J Pediatr Surg. 2015;50(5):707–14.
Srivastava R, Downey EC, O’Gorman M, et al. Impact of fundoplication versus gastrojejunal feeding tubes on mortality and in preventing aspiration pneumonia in young children with neurologic impairment who have gastroesophageal reflux disease. Pediatrics. 2009;123(1):338–45.
Ishii D, Miyamoto K, Hirasawa M, et al. Preferential performance of Thal fundoplication for gastroesophageal reflux disease: a single institution experience. Pediatr Surg Int. 2021;37:191–6.
Ishak A, Al-Bayati I, Davis B, et al. Efficacy and safety of Dor fundoplication in patients with severe gastroparesis and refractory gastroesophageal reflux disease. Gastrointest Disord. 2020;2:134–9.
Wenck C, Zornig C, Wenck C, et al. Laparoscopic Toupet fundoplication. Langenbeck’s Arch Surg. 2010;395:459–61.
Frazzoni M, Frazzoni L, Piccoli M, et al. Topic highlight laparoscopic fundoplication for gastroesophageal reflux disease. World J Gastroenterol. 2014;20:14272–9.
Coletta R, Mussi E, Bianchi A, et al. Modified oesophago-gastric dissociation (M-OGD)—a technical modification. Updat Surg. 2021;73:775–8.
Hassall E. Outcomes of fundoplication: causes for concern, newer options. Arch Dis Child. 2005;90(10):1047–52.
Koivusalo AI, Pakarinen MP. Outcome of surgery for pediatric gastroesophageal reflux: clinical and endoscopic follow-up after 300 fundoplications in 279 consecutive patients. Scand J Surg. 2018;107(1):68–75.
Orenstein SR, Di Lorenzo C. Post fundoplication complications in children. Curr Treat Options Gastroenterol. 2001;4:441–9.
Krishnan U, Mousa H, Dall’Oglio L, et al. ESPGHAN-NASPGHAN guidelines for the evaluation and treatment of gastrointestinal and nutritional complications in children with esophageal atresia-tracheoesophageal fistula. J Pediatr Gastroenterol Nutr. 2016;63(5):550–70.
Richards CA, Carr D, Spitz L, et al. Nissen-type fundoplication and its effects on the emetic reflex and gastric motility in the ferret. Neurogastroenterol Motil. 2000;12:65–74.
Richards CA. Postfundoplication retching: strategies for management. J Pediatr Surg. 2020;55(9):1779–95.
DeVault KR, Swain JM, Wentling GK, et al. Evaluation of vagus nerve function before and after antireflux surgery. J Gastrointest Surg. 2004;8(7):883–8.
Vu MK, Ringers J, Arndt JW, et al. Prospective study of the effect of laparoscopic hemifundoplication on motor and sensory function of the proximal stomach. Br J Surg. 2000;87(3):338–43.
Mousa H, Caniano DA, Alhajj M, et al. Effect of Nissen fundoplication on gastric motor and sensory functions. J Pediatr Gastroenterol Nutr. 2006;43(2):185–9.
Samuk I, Afriat R, Horne T, et al. Dumping syndrome following Nissen fundoplication, diagnosis, and treatment. J Pediatr Gastroenterol Nutr. 1996;23(3):235–40.
Richards CA, Andrews PLR, Spitz L, et al. Nissen fundoplication may induce gastric myoelectrical disturbance in children. J Pediatr Surg. 1998;33(12):1801–5.
Richards CA, Milla PJ, Andrews PLR, et al. Retching and vomiting in neurologically impaired children after fundoplication: predictive preoperative factors. J Pediatr Surg. 2001;36:1401–4.
Tian ZC, Wang B, Shan CX, et al. A meta-analysis of randomized controlled trials to compare long-term outcomes of Nissen and Toupet fundoplication for gastroesophageal reflux disease. PLoS ONE. 2015;10(6):e0127627.
Cook RC, Blinman TA. Alleviation of retching and feeding intolerance after fundoplication. Nutr Clin Pract. 2014;29:386–96.
Marjoux S, Roman S, Juget-Pietu F, et al. Impaired postoperative EGJ relaxation as a determinant of post laparoscopic fundoplication dysphagia: a study with high-resolution manometry before and after surgery. Surg Endosc. 2012;26(12):3642–9.
Omari T, Connor F, McCall L, et al. A study of dysphagia symptoms and esophageal body function in children undergoing anti-reflux surgery. United European Gastroenterol J. 2018;6(6):819–29.
Loots C, van Herwaarden MY, Benninga MA, et al. Gastroesophageal reflux, esophageal function, gastric emptying, and the relationship to dysphagia before and after antireflux surgery in children. J Pediatr. 2013;162(3):566–73.
Chrysos E, Tsiaoussis J, Zoras OJ, et al. Laparoscopic surgery for gastroesophageal reflux disease patients with impaired esophageal peristalsis: total or partial fundoplication. J Am Coll Surg. 2003;197:8–15.
Mello MD, Shriver AR, Li Y, et al. Ineffective esophageal motility phenotypes following fundoplication in gastroesophageal reflux disease. Neurogastroenterol Motil. 2016;28:292–8.
Wang YT, Tai LF, Yazaki E, et al. Investigation of dysphagia after antireflux surgery by high-resolution manometry: impact of multiple water swallows and a solid test meal on diagnosis, management, and clinical outcome. Clin Gastroenterol Hepatol. 2015;13:1575–83.
Myers JC, Nguyen NQ, Jamieson GG, et al. Susceptibility to dysphagia after fundoplication revealed by novel automated impedance manometry analysis. Neurogastroenterol Motil. 2012;24(9):812.e393.
Ngerncham M, Barnhart DC, Haricharan RN, et al. Risk factors for recurrent gastroesophageal reflux disease after fundoplication in pediatric patients: a case-control study. J Pediatr Surg. 2007;42:1478–85.
Capito C, Leclair MD, Piloquet H, et al. Long-term outcome of laparoscopic Nissen-Rossetti fundoplication for neurologically impaired and normal children. Surg Endosc Other Interv Tech. 2008;22(4):875–80.
Rothenberg SS. The first decade’s experience with laparoscopic Nissen fundoplication in infants and children. J Pediatr Surg. 2005;40:142–7.
Del Giudice E, Staiano A, Capano G, et al. Gastrointestinal manifestations in children with cerebral palsy. Brain and Development. 1999;21(5):307–11.
Sullivan PB. Gastrointestinal disorders in children with neurodevelopmental disabilities. Dev Disabil Res Rev. 2008;14:128–36.
Ferluga ED, Sathe NA, Krishnaswami S, et al. Surgical intervention for feeding and nutrition difficulties in cerebral palsy: a systematic review. Dev Med Child Neurol. 2014;56(1):31–43.
Goldin AB, Sawin R, Seidel KD, et al. Do antireflux operations decrease the rate of reflux-related hospitalizations in children? Pediatrics. 2006;118(6):2326–33.
Lee SL, Shabatian H, Hsu JW, et al. Hospital admissions for respiratory symptoms and failure to thrive before and after Nissen fundoplication. J Pediatr Surg. 2008;43(1):59–63.
Razeghi S, Lang T, Behrens R. Influence of percutaneous endoscopic gastrostomy on gastroesophageal reflux: a prospective study in 68 children. J Pediatr Gastroenterol Nutr. 2002;35(1):27–30.
Vernon-Roberts A, Sullivan P. Fundoplication versus post-operative medication for gastro-oesophageal reflux in children with neurological impairment undergoing gastrostomy. Cochrane Database Syst Rev. 2006;2013(8):CD006151.
Novotny NM, Jester AL, Ladd AP. Preoperative prediction of need for fundoplication before gastrostomy tube placement in children. J Pediatr Surg. 2009;44(1):173–6.
Sullivan PB. Gastrostomy feeding in the disabled child: when is an antireflux procedure required? Arch Dis Child. 1999;81:463–4.
Esposito C, van der Zee DC, Settimi A, et al. Risks and benefits of surgical management of gastroesophageal reflux in neurologically impaired children. Surg Endosc Other Interv Tech. 2003;17:708–10.
Barnhart DC, Hall M, Mahant S, et al. Effectiveness of fundoplication at the time of gastrostomy in infants with neurological impairment. JAMA Pediatr. 2013;167(10):911–8.
Toporowska-Kowalska E, Ebora-Kowalska B, Fendler W, et al. Diagnosis of gastroesophageal reflux and anti-reflux procedures among polish children with gastrostomies: a 10-year nationwide analysis. Eur J Clin Nutr. 2013;67:1169–74.
Rosen R, Levine P, Lewis J, et al. Reflux events detected by pH-MII do not determine fundoplication outcome. J Pediatr Gastroenterol Nutr. 2010;50:251–5.
Schneider A, Gottrand F, Bellaiche M, et al. Prevalence of barrett esophagus in adolescents and young adults with esophageal atresia. Ann Surg. 2016;264(6):1004–8.
Vergouwe FWT, Ijsselstijn H, Biermann K, et al. High prevalence of Barrett’s esophagus and esophageal squamous cell carcinoma after repair of esophageal atresia. Clin Gastroenterol Hepatol. 2018;16:513–521.e6.
Taylor ACF, Breen KJ, Auldist A, et al. Gastroesophageal reflux and related pathology in adults who were born with esophageal atresia: a long-term follow-up study. Clin Gastroenterol Hepatol. 2007;5:702–6.
Vergouwe FWT, Vlot J, Ijsselstijn H, et al. Risk factors for refractory anastomotic strictures after oesophageal atresia repair: a multicentre study. Arch Dis Child. 2019;104(2):152–7.
Vergouwe FWT. Long-term follow-up after esophageal atresia repair gastrointestinal morbidity in children and adults. Ann Surg. 2017;266:e95–6.
Rintala RJ. Fundoplication in patients with esophageal atresia: patient selection, indications, and outcomes. Front Pediatr. 2017;5:109.
Koivusalo AI, Rintala RJ, Pakarinen MP. Outcomes of fundoplication in oesophageal atresia associated gastrooesophageal reflux disease. J Pediatr Surg. 2018;53(2):230–3.
Lemoine C, Aspirot A, le Henaff G, et al. Characterization of esophageal motility following esophageal atresia repair using high-resolution esophageal manometry. J Pediatr Gastroenterol Nutr. 2013;56:609–14.
Mousa H, Krishnan U, Hassan M, et al. How to care for patients with EA-TEF: the known and the unknown. Curr Gastroenterol Rep. 2017;19(12):65.
van Lennep M, Singendonk MMJ, Dall’Oglio L, et al. Oesophageal atresia. Nat Rev Dis Primers. 2019;5(1):26.
Yasuda JL, Clark SJ, Staffa SJ, et al. Esophagitis in pediatric esophageal atresia: acid may not always be the issue. J Pediatr Gastroenterol Nutr. 2019;69:163–70.
Vergouwe FWT, van Wijk MP, Spaander MCW, et al. Evaluation of gastroesophageal reflux in children born with esophageal atresia using pH and impedance monitoring. J Pediatr Gastroenterol Nutr. 2019;69(5):515–22.
Petit LM, Righini-Grunder F, Ezri J, et al. Prevalence and predictive factors of histopathological complications in children with esophageal atresia. Eur J Pediatr Surg. 2019;29(6):510–5.
Tambucci R, Isoldi S, Angelino G, et al. Evaluation of gastroesophageal reflux disease 1 year after esophageal atresia repair: paradigms lost from a single snapshot? J Pediatr. 2021;228:155–163.e1.
Courbette O, Omari T, Aspirot A, et al. Characterization of esophageal motility in children with operated esophageal atresia using high-resolution impedance manometry and pressure flow analysis. J Pediatr Gastroenterol Nutr. 2020;71(3):304–9.
Tambucci R, Rea F, Angelino G, et al. Eosinophilic esophagitis in esophageal atresia: tertiary care experience of a “selective” approach for biopsy sampling. World Allergy Organ J. 2020;13(4):100116.
Tambucci R, Angelino G, de Angelis P, et al. Anastomotic strictures after esophageal atresia repair: incidence, investigations, and management, including treatment of refractory and recurrent strictures. Front Pediatr. 2017;5:120.
Stenström P, Anderberg M, Börjesson A, et al. Prolonged use of proton pump inhibitors as stricture prophylaxis in infants with reconstructed esophageal atresia. Eur J Pediatr Surg. 2017;27(2):192–5.
Donoso F, Lilja HE. Risk factors for anastomotic strictures after esophageal atresia repair: prophylactic proton pump inhibitors do not reduce the incidence of strictures. Eur J Pediatr Surg. 2017;27(1):50–5.
Grunder FR, Petit LM, Ezri J, et al. Should proton pump inhibitors be systematically prescribed in patients with esophageal atresia after surgical repair? J Pediatr Gastroenterol Nutr. 2019;69(1):45–51.
Miyake H, Chen Y, Hock A, et al. Are prophylactic anti-reflux medications effective after esophageal atresia repair? Systematic review and meta-analysis. Pediatr Surg Int. 2018;34:491–7.
Jönsson L, Dellenmark-Blom M, Enoksson O, et al. Long-term effectiveness of antireflux surgery in esophageal atresia patients. Eur J Pediatr Surg. 2019;29:521–7.
van Lennep M, Chung E, Jiwane A, et al. Fundoplication in children with esophageal atresia: preoperative workup and outcome. Dis Esophagus. 2022; https://doi.org/10.1093/dote/doac006.
Diamanti A, Fusaro F, Caldaro T, et al. Pediatric intestinal pseudo-obstruction: impact of neonatal and later onset on clinical and nutritional outcomes. J Pediatr Gastroenterol Nutr. 2019;69:212–7.
Thapar N, Saliakellis E, Benninga MA, et al. Paediatric intestinal pseudo-obstruction: evidence and consensus-based recommendations from an ESPGHAN-Led Expert Group. J Pediatr Gastroenterol Nutr. 2018;66:991–1019.
Zenzeri L, Tambucci R, Quitadamo P, et al. Update on chronic intestinal pseudo-obstruction. Curr Opin Gastroenterol. 2020;36:230–7.
Downes TJ, Cheruvu MS, Karunaratne TB, et al. Pathophysiology, diagnosis, and management of chronic intestinal pseudo-obstruction. J Clin Gastroenterol. 2018;52:477–89.
Goulet O, Jobert-Giraud A, Michel J-L, et al. Chronic intestinal pseudo-obstruction syndrome in pediatric patients. Eur J Pediatr Surg. 1997;9(2):83–90.
Goulet O, Sauvat F, Jan D. Surgery for pediatric patients with chronic intestinal pseudo-obstruction syndrome. J Pediatr Gastroenterol Nutr. 2005;41:S66–8.
Lindberg G, Törnblom H, Iwarzon M, et al. Full-thickness biopsy findings in chronic intestinal pseudo-obstruction and enteric dysmotility. Gut. 2009;58:1084–90.
Pitt HA, Mann LL, Berquist WE, et al. Chronic intestinal pseudo-obstruction management with total parenteral nutrition and a venting enterostomy from the Departments of Surgery. Arch Surg. 1985;120:614–8.
Chun C, Aulakh S, Komlos F, et al. Tube to freedom: use of a venting jejunostomy in a patient with chronic intestinal pseudo-obstruction. Dig Dis Sci. 2012;57:3076–9.
Ohkubo H, Fuyuki A, Arimoto J, et al. Efficacy of percutaneous endoscopic gastro-jejunostomy (PEG-J) decompression therapy for patients with chronic intestinal pseudo-obstruction (CIPO). Neurogastroenterol Motil. 2017;29:13127.
Homan M, Hauser B, Romano C, et al. Percutaneous endoscopic gastrostomy in children: an update to the ESPGHAN Position Paper. J Pediatr Gastroenterol Nutr. 2021;73:415–26.
Vriesman MH, Noor N, Koppen IJ, et al. Outcomes after enterostomies in children with and without motility disorders: a description and comparison of postoperative complications. J Pediatr Surg. 2020;55:2413–8.
de Betue CT, Boersma D, Oomen MW, et al. Volvulus as a complication of chronic intestinal pseudo-obstruction syndrome. Eur J Pediatr. 2011;170:1591–5.
Kim HY, Kim JH, Jung SE, et al. Surgical treatment and prognosis of chronic intestinal pseudo-obstruction in children. J Pediatr Surg. 2005;40:1753–9.
de Lorijn F, Boeckxstaens GE, Benninga MA. Symptomatology, pathophysiology, diagnostic work-up, and treatment of Hirschsprung disease in infancy and childhood. Curr Gastroenterol Rep. 2007;9:245–53.
Ryan ET, Ecker JL, Christakis NA, et al. Hirschsprung’s disease: associated abnormalities and demography. J Pediatr Surg. 1992;27:76–81.
Haricharan RN, Georgeson KE. Hirschsprung disease. Semin Pediatr Surg. 2008;17:266–75.
de Lorijn F, Kremer CM, Reitsma JB, et al. Diagnostic tests in Hirschsprung disease: a systematic review. J Pediatr Gastroenterol Nutr. 2006;42(5):496–505.
Amiel J, Sproat-Emison E, Garcia-Barcelo M, et al. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 2007;45:1–14.
Alves MM, Sribudiani Y, Brouwer RWW, et al. Contribution of rare and common variants determine complex diseases-Hirschsprung disease as a model. Dev Biol. 2013;382:320–9.
Martucciello G. Hirschsprung’s disease, one of the most difficult diagnoses in pediatric surgery: a review of the problems from clinical practice to the bench. Eur J Pediatr Surg. 2008;18:140–9.
Martin Bodian B. A family study of Hirschsprung’s disease morbid anatomy. Ann Hum Genet. 1963;26:281.
Parisi MA, Kapur RP. Genetics of Hirschsprung disease. Curr Opin Pediatr. 2000;12:610–7.
Amiel J, Lyonnet S. Hirschsprung disease, associated syndromes, and genetics: a review. J Med Genet. 2001;38:729–39.
Mulligan LM, Ponder BAJ. Genetic basis of endocrine disease: multiple endocrine neoplasia type 2. J Clin Endocrinol Metab. 1995;80(7):1989–95.
Moore SW, Zaahl M. Familial associations in medullary thyroid carcinoma with Hirschsprung disease: the role of the RET-C620 “Janus” genetic variation. J Pediatr Surg. 2010;45:393–6.
Kyrklund K, Sloots CEJ, de Blaauw I, et al. ERNICA guidelines for the management of rectosigmoid Hirschsprung’s disease. Orphanet J Rare Dis. 2020;15:164–80.
Hackam DJ, Reblock AKK, Redlinger ARE, et al. Diagnosis and outcome of Hirschsprung’s disease: does age really matter? Pediatr Surg Int. 2004;20:319–22.
Teitelbaum DH, Cilley RE, Sherman NJ, et al. A decade of experience with the primary pull-through for Hirschsprung disease in the newborn period a multicenter analysis of outcomes. Ann Surg. 2000;3:372–80.
Diamond IR, Casadiego G, Traubici J, et al. The contrast enema for Hirschsprung disease: predictors of a false-positive result. J Pediatr Surg. 2007;42:792–5.
Bill AH, And JR, Chapman ND. The enterocolitis of Hirschsprung’s disease its natural history and treatment. Am J Surg. 1962;103(1):70–4.
Tambucci R, Quitadamo P, Thapar N, et al. Diagnostic tests in pediatric constipation. J Pediatr Gastroenterol Nutr. 2018;66:e89–98.
Jamieson DH, Dundas SE, al Belushi S, et al. Does the transition zone reliably delineate aganglionic bowel in Hirschsprung’s disease? Pediatr Radiol. 2004;34:811–5.
Proctor ML, Traubici J, Langer JC, et al. Correlation between radiographic transition zone and level of aganglionosis in Hirschsprung’s disease: implications for surgical approach. J Pediatr Surg. 2003;38(5):775–8.
Pratap A, Gupta DK, Tiwari A, et al. Application of a plain abdominal radiograph transition zone (PARTZ) in Hirschsprung’s disease. BMC Pediatr. 2007;7:5.
Gonzalo DH, Plesec T. Hirschsprung disease and use of calretinin in inadequate rectal suction biopsies. Arch Pathol Lab Med. 2013;137(8):1099–102.
Knowles CH, De Giorgio R, Kapur RP, et al. The London Classification of gastrointestinal neuromuscular pathology: report on behalf of the Gastro 2009 International Working Group. Gut. 2010;52:882–7.
Schäppi MG, Staiano A, Milla PJ, et al. A practical guide for the diagnosis of primary enteric nervous system disorders. J Pediatr Gastroenterol Nutr. 2013;57(5):677–86.
Frykman PK, Short SS. Hirschsprung-associated enterocolitis: prevention and therapy. Semin Pediatr Surg. 2012;21(4):328–35.
Langer JC, Rollins MD, Levitt M, et al. Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease. Pediatr Surg Int. 2017;33:523–6.
Hukkinen M, Koivusalo A, Rintala RJ, et al. Restorative proctocolectomy with J-pouch ileoanal anastomosis for total colonic aganglionosis among neonates and infants. J Pediatr Surg. 2014;49:570–4.
Swenson O. My early experience with Hirschsprung’s disease. J Pediatr Surg. 1989;24(8):839–44.
Sherman JO, Snyder ME, Weitzman JJ, et al. A 40-year multinational retrospective study of 880 Swenson procedures. J Pediatr Surg. 1989;24(8):833–8.
Langer JC. Hirschsprung disease. In: Wyllie R, Hyams JS, Kay M, editors. Pediatric gastrointestinal and liver disease. 6th ed. Elsevier; 2020. p. 566.
Soave F. Hirschsprung’s disease: a new surgical technique. Arch Dis Child. 1964;39(204):116–24.
Boley SJ. New modification of the surgical treatment of Hirschsprung’s disease. Surgery. 1964;56:1015.
De La Torre-Mondragh BL, Ortega-Salgado J. Transanal endorectal pull-through for Hirschsprung’s disease. J Pediatr Surg. 1998;33:1983–6.
De La Torre L, Ortega A. Transanal versus open endorectal pull-through for Hirschsprung’s disease. J Pediatr Surg. 2000;35(11):1630–2.
Georgeson KE, Fuenfer MM, Hardin WD. Primary laparoscopic pull-through for Hirschsprung’s disease in infants and children. J Pediatr Surg. 1993;30:1017–20.
Delgado-Miguel C, Camps JI. Robotic Soave pull-through procedure for Hirschsprung’s disease in children under 12-months: long-term outcomes. Pediatr Surg Int. 2022;38(1):51–7.
Pini Prato A, Arnoldi R, Dusio MP, et al. Totally robotic soave pull-through procedure for Hirschsprung’s disease: lessons learned from 11 consecutive pediatric patients. Pediatr Surg Int. 2020;36:209–18.
Mattioli G, Pio L, Leonelli L, et al. A provisional experience with robot-assisted Soave procedure for older children with Hirschsprung disease: back to the future? J Laparoendosc Adv Surg Tech A. 2017;27:546–9.
Martin LW. Surgical management of Hirschsprung’s disease involving the small intestine. Arch Surg. 1968;97:103–9.
Kimura KB, Nishijima E, Muraji T, et al. Extensive aganglionosis: further experience with the colonic patch graft procedure and long-term results clinical series. J Pediatr Surg. 1988;23:52–6.
Tsuji H, Spitz L, Kiely EM, et al. Management and long-term follow-up of infants with total colonic aganglionosis. J Pediatr Surg. 1999;34:158–62.
Coran AG, Teitelbaum DH, Arbor A. Recent advances in the management of Hirschsprung’s disease. Am J Surg. 2000;180:382–7.
Rintala RJ, Lindahl HG. Proctocolectomy and J-pouch ileo-anal anastomosis in children. J Pediatr Surg. 2002;37(1):66–70.
Meier-Ruge W. Ultrashort segment Hirschsprung disease. an objective picture of the disease substantiated by biopsy. Z Kinderchir. 1985;40:146–50.
Osifo OD, Okolo CK. Outcome of trans-anal posterior anorectal myectomy for the ultrashort segment Hirschsprung’s disease–Benin City experience in five years. Niger Postgrad Med J. 2009;16:213–7.
Meier-Ruge WA, Bruder E, Holschneider AM, et al. Diagnosis and therapy of ultrashort Hirschsprung’s disease. Eur J Pediatr Surg. 2004;14:392–7.
Gustafsson UO, Scott MJ, Hubner M, et al. Guidelines for perioperative care in elective colorectal surgery: enhanced recovery after surgery (ERAS) society recommendations: 2018. World J Surg. 2019;43:659–95.
Polley TZ, Coran AG, Wesley JR. A ten-year experience with ninety-two cases of Hirschsprung’s disease including sixty-seven consecutive endorectal pull-through procedures. Ann Surg. 1985;202:349–55.
Fortuna RS, Weber TR, Tracy TF, et al. Critical analysis of the operative treatment of Hirschsprung’s disease. Arch Surg. 1996;131:520–4.
Tariq GM, Brereton RJ, Wright VM. Complications of endorectal pull-through for Hirschsprung’s disease. J Pediatr Surg. 1991;26:1202–6.
Little DC, Snyder CL. Early and late complications following operative repair of Hirschsprung’s disease. In: Holschneider AM, Puri P, editors. Hirschsprung’s disease and allied disorders. 3rd ed. New York: Springer; 2008. p. 375–85.
Seo S, Miyake H, Hock A, et al. Duhamel and transanal endorectal pull-throughs for Hirschsprung’ disease: a systematic review and meta-analysis. Eur J Pediatr Surg. 2018;28:81–8.
Engum SA, Grosfeld JL. Long-term results of treatment of Hirschsprung’s disease. Semin Pediatr Surg. 2004;13:273–85.
Menezes M, Puri P. Long-term outcome of patients with enterocolitis complicating Hirschsprung’s disease. Pediatr Surg Int. 2006;22:316–8.
Meinds RJ, van der Steeg AFW, Sloots CEJ, et al. Long-term functional outcomes and quality of life in patients with Hirschsprung’s disease. Br J Surg. 2019;106:499–507.
Neuvonen MI, Kyrklund K, Rintala JR. Bowel function and quality of life after transanal endorectal pullthrough for Hirschsprung disease: controlled outcomes up to adulthood. Ann Surg. 2017;265:622–9.
Aworanti OM, Mcdowell DT, Martin IM, et al. Comparative review of functional outcomes post surgery for Hirschsprung’s disease utilizing the paediatric incontinence and constipation scoring system. Pediatr Surg Int. 2012;28:1071–8.
Wester T, Granström AL. Hirschsprung disease—bowel function beyond childhood. Semin Pediatr Surg. 2017;26(5):322–7.
Hyman PE. Defecation disorders after surgery for Hirschsprung’s disease. J Pediatr Gastroenterol Nutr. 2005;41:S62–3.
Ralls MW, Coran AG, Teitelbaum DH. Reoperative surgery for Hirschsprung disease. Semin Pediatr Surg. 2012;21(4):354–63.
Lawal TA, Chatoorgoon K, Collins MH, et al. Redo pull-through in Hirschprung’s disease for obstructive symptoms due to residual aganglionosis and transition zone bowel. J Pediatr Surg. 2011;46:342–7.
Han-Geurts IJM, Hendrix VC, de Blaauw I, et al. Outcome after anal intrasphincteric Botox injection in children with surgically treated Hirschsprung disease. J Pediatr Gastroenterol Nutr. 2014;59:604–7.
Roorda D, Oosterlaan J, van Heurn E, et al. Intrasphincteric botulinum toxin injections for post-operative obstructive defecation problems in Hirschsprung disease: a retrospective observational study. J Pediatr Surg. 2021;56(8):1342–8.
Bischoff A, Frischer J, Knod JL, et al. Damaged anal canal as a cause of fecal incontinence after surgical repair for Hirschsprung disease—a preventable and under-reported complication. J Pediatr Surg. 2017;52:549–53.
Stensrud KJ, Emblem R, Bjørnland K. Anal endosonography and bowel function in patients undergoing different types of endorectal pull-through procedures for Hirschsprung disease. J Pediatr Surg. 2015;50(8):1341–6.
Keshtgar AS, Ward AHC, Clayden AGS, et al. Investigations for incontinence and constipation after surgery for Hirschsprung’s disease in children. Pediatr Surg Int. 2003;19:4–8.
Sakurai T, Tanaka H, Endo N. Predictive factors for the development of postoperative Hirschsprung-associated enterocolitis in children operated during infancy. Pediatr Surg Int. 2021;37(2):275–80.
Gosain A, Brinkman AS. Hirschsprung’s associated enterocolitis. Curr Opin Pediatr. 2015;27:364–9.
Saadai P, Trappey AF, Goldstein AM, et al. Guidelines for the management of postoperative soiling in children with Hirschsprung disease. J Pediatr Surg. 2019;54:2017–23.
Halleran DR, Lu PL, Ahmad H, et al. Anal sphincter botulinum toxin injection in children with functional anorectal and colonic disorders: a large institutional study and review of the literature focusing on complications. J Pediatr Surg. 2019;54(11):2305–10.
Louis-Borrione C, Faure A, Garnier S, et al. Neurostimulation-guided anal intrasphincteric botulinum toxin injection in children with hirschsprung disease. J Pediatr Gastroenterol Nutr. 2019;68(4):527–32.
Wester T, Granström AL. Botulinum toxin is efficient to treat obstructive symptoms in children with Hirschsprung disease. Pediatr Surg Int. 2015;31:255–9.
Patrus B, Nasr A, Langer JC, et al. Intrasphincteric botulinum toxin decreases the rate of hospitalization for postoperative obstructive symptoms in children with Hirschsprung disease. J Pediatr Surg. 2011;46(1):184–7.
Chumpitazi BP, Nurko S. Defecation disorders in children after surgery for hirschsprung disease. J Pediatr Gastroenterol Nutr. 2011;53(1):75–9.
Koivusalo AI, Pakarinen MP, Rintala RJ. Botox injection treatment for anal outlet obstruction in patients with internal anal sphincter achalasia and Hirschsprung’s disease. Pediatr Surg Int. 2009;25(10):873–6.
Martins EC, Peterlini FL, Fagundes DJ, et al. Clinical, manometric and profilometric evaluation after surgery for Hirschsprung’s disease: comparison between the modified Duhamel and the transanal rectosigmoidectomy techniques. Acta Cir Bras. 2009;24:416–22.
van Leeuwen K, Geiger JD, Barnett JL, et al. Stooling and manometric findings after primary pull-throughs in Hirschsprung’s disease: perineal versus abdominal approaches. J Pediatr Surg. 2002;37:1321–5.
Zhong MY, Tao TS, Li S, et al. Duhamel operation vs. transanal endorectal pull-through procedure for Hirschsprung disease: a systematic review and meta-analysis. J Pediatr Surg. 2018;53:1710–5.
Yan BL, Bi LW, Yang QY, et al. Transanal endorectal pull-through procedure versus transabdominal surgery for Hirschsprung disease: a systematic review and meta-analysis. Medicine (United States). 2019;98(32):e16777.
Moore SW, Albertyn R, Cywes Tygerberg S. Clinical outcome and long-term quality of life after surgical correction of Hirschsprung’s disease. J Pediatr Surg. 1996;31:1496–502.
Swenson O. Hirschsprung’s disease—a complicated therapeutic problem: some thoughts and solutions based on data and personal experience over 56 years. J Pediatr Surg. 2004;39:1449–53.
Chatoorgoon K, Pena A, Lawal TA, et al. The problematic duhamel pouch in hirschsprungs disease: manifestations and treatment. Eur J Pediatr Surg. 2011;21:366–9.
Widyasari A, Alda Pavitasari W, Dwihantoro A. Effectiveness of concomitant use of green tea and polyethylene glycol in bowel preparation for colonoscopy: a randomized controlled study. BMC Gastroenterol. 2021;21(1):357.
Rintala RJ, Pakarinen MP. Long-term outcome of Hirschsprung’s disease. Semin Pediatr Surg. 2012;21:336–43.
Menezes M, Corbally M, Puri P. Long-term results of bowel function after treatment for Hirschsprung’s disease: a 29-year review. Pediatr Surg Int. 2006;22:987–90.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
De Angelis, P. et al. (2022). Surgery in Motility Disorders. In: Faure, C., Thapar, N., Di Lorenzo, C. (eds) Pediatric Neurogastroenterology. Springer, Cham. https://doi.org/10.1007/978-3-031-15229-0_50
Download citation
DOI: https://doi.org/10.1007/978-3-031-15229-0_50
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-15228-3
Online ISBN: 978-3-031-15229-0
eBook Packages: MedicineMedicine (R0)